{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:23:34Z","timestamp":1793748214459,"version":"4.6.1"},"reference-count":384,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Program for Clinical Research Excellence in Research-Oriented Inpatient Units"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11010-025-05379-9","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:32:54Z","timestamp":1757485974000},"page":"6039-6075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms\u2013a comprehensive review"],"prefix":"10.1007","volume":"480","author":[{"given":"Zhen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"5379_CR1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. Available from: https:\/\/diabetesatlas.org"},{"issue":"08","key":"5379_CR2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3760\/cma.j.cn112138-20221013-00755","volume":"62","author":"CPM Association","year":"2023","unstructured":"Association CPM, Prevention N, Committee C (2023) Guidelines for early evaluation and management of chronic kidney disease in China. Zhonghua Neike Zazhi 62(08):902\u2013930. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20221013-00755","journal-title":"Zhonghua Neike Zazhi"},{"key":"5379_CR3","unstructured":"The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary. Zhonghua Xunhuan Yixue Zazhi. 2023;(06):583\u2013612"},{"issue":"20","key":"5379_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, Rangaswami J, American Heart Association (2023) A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the american heart association. Circulation 148(20):1636\u20131664. https:\/\/doi.org\/10.1161\/CIR.0000000000001186","journal-title":"Circulation"},{"issue":"21","key":"5379_CR5","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","volume":"330","author":"H Larkin","year":"2023","unstructured":"Larkin H (2023) Here\u2019s what to know about cardiovascular-kidney-metabolic syndrome. Newly Defined AHA JAMA 330(21):2042\u20132043. https:\/\/doi.org\/10.1001\/jama.2023.22276","journal-title":"Newly Defined AHA JAMA"},{"issue":"21","key":"5379_CR6","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M (2024) Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA 331(21):1858\u20131860. https:\/\/doi.org\/10.1001\/jama.2024.6892","journal-title":"JAMA"},{"issue":"8","key":"5379_CR7","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147(8):e93\u2013e621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"issue":"12","key":"5379_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","volume":"18","author":"T Speer","year":"2022","unstructured":"Speer T, Dimmeler S, Schunk SJ, Fliser D, Ridker PM (2022) Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat Rev Nephrol 18(12):762\u2013778. https:\/\/doi.org\/10.1038\/s41581-022-00621-9","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"5379_CR9","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","volume":"38","author":"JL Silveira Rossi","year":"2022","unstructured":"Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA (2022) Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev 38(3):e3502. https:\/\/doi.org\/10.1002\/dmrr.3502","journal-title":"Diabetes Metab Res Rev"},{"issue":"20","key":"5379_CR10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, American Heart Association (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/CIR.0000000000001184","journal-title":"Circulation"},{"key":"5379_CR11","doi-asserted-by":"publisher","first-page":"118585","DOI":"10.1016\/j.atherosclerosis.2024.118585","volume":"397","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, Chen S, Liu B, Shi H, Gao H, Huang T, Gao X, Geng T, Wu S (2024) Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality. Atherosclerosis 397:118585. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118585","journal-title":"Atherosclerosis"},{"key":"5379_CR12","doi-asserted-by":"publisher","first-page":"111926","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Virginia Manzi M, Trama U, Lembo M, Piccinocchi R, Gallo P, Esposito G, Morisco C, Rozza F, Mone P, Jankauskas SS, Piccinocchi G, Santulli G, Trimarco B (2024) Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: a propensity score-matched study. Diabetes Res Clin Pract 218:111926. https:\/\/doi.org\/10.1016\/j.diabres.2024.111926","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"5379_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, Liu Z, Zheng L (2024) Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol 23(1):292. https:\/\/doi.org\/10.1186\/s12933-024-02352-6","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5379_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-025-02689-6","volume":"24","author":"MY Tan","year":"2025","unstructured":"Tan MY, Zhang YJ, Zhu SX, Wu S, Zhang P, Gao M (2025) The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies. Cardiovasc Diabetol 24(1):137. https:\/\/doi.org\/10.1186\/s12933-025-02689-6","journal-title":"Cardiovasc Diabetol"},{"issue":"22","key":"5379_CR15","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3390\/nu16223948.PMID:39599733;PMCID:PMC11597375","volume":"16","author":"A Ruiz-Garc\u00eda","year":"2024","unstructured":"Ruiz-Garc\u00eda A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Mart\u00ednez E, Pallar\u00e9s-Carratal\u00e1 V (2024) Prevalence rates of abdominal obesity, high waist-to-height ratio and excess adiposity, and their associated cardio-kidney-metabolic factors: SIMETAP-AO study. Nutrients 16(22):3948. https:\/\/doi.org\/10.3390\/nu16223948.PMID:39599733;PMCID:PMC11597375","journal-title":"Nutrients"},{"issue":"8","key":"5379_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41574-019-0219-1","volume":"15","author":"E Larqu\u00e9","year":"2019","unstructured":"Larqu\u00e9 E, Labayen I, Flodmark CE, Lissau I, Czernin S, Moreno LA, Pietrobelli A, Widhalm K (2019) From conception to infancy\u2014early risk factors for childhood obesity. Nat Rev Endocrinol 15(8):456\u2013478. https:\/\/doi.org\/10.1038\/s41574-019-0219-1","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"5379_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2021","unstructured":"Robbins PD, Jurk D, Khosla S, Kirkland JL, LeBrasseur NK, Miller JD, Passos JF, Pignolo RJ, Tchkonia T, Niedernhofer LJ (2021) Senolytic drugs: reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol 61(1):779\u2013803. https:\/\/doi.org\/10.1146\/annurev-pharmtox-050120-105018","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"17","key":"5379_CR18","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.3390\/ijms21176358","volume":"21","author":"B Lair","year":"2020","unstructured":"Lair B, Laurens C, Van Den Bosch B, Moro C (2020) Novel insights and mechanisms of lipotoxicity-driven insulin resistance. Int J Mol Sci 21(17):6358. https:\/\/doi.org\/10.3390\/ijms21176358","journal-title":"Int J Mol Sci"},{"issue":"5091","key":"5379_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87\u201391. https:\/\/doi.org\/10.1126\/science.7678183","journal-title":"Science"},{"issue":"5535","key":"5379_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535):1673\u20131677. https:\/\/doi.org\/10.1126\/science.1061620","journal-title":"Science"},{"issue":"2","key":"5379_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nm1185","volume":"11","author":"MC Arkan","year":"2005","unstructured":"Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11(2):191\u2013198. https:\/\/doi.org\/10.1038\/nm1185","journal-title":"Nat Med"},{"issue":"6913","key":"5379_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, Tuncman G, Chang L, G\u00f6rg\u00fcn CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) A central role for JNK in obesity and insulin resistance. Nature 420(6913):333\u2013336. https:\/\/doi.org\/10.1038\/nature01137","journal-title":"Nature"},{"issue":"12","key":"5379_CR23","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI19246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796\u20131808. https:\/\/doi.org\/10.1172\/JCI19246","journal-title":"J Clin Invest"},{"issue":"12","key":"5379_CR24","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI19451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821\u20131830. https:\/\/doi.org\/10.1172\/JCI19451","journal-title":"J Clin Invest"},{"issue":"3","key":"5379_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.3","volume":"2","author":"SJ Bigornia","year":"2012","unstructured":"Bigornia SJ, Farb MG, Mott MM, Hess DT, Carmine B, Fiscale A, Joseph L, Apovian CM, Gokce N (2012) Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2(3):e30. https:\/\/doi.org\/10.1038\/nutd.2012.3","journal-title":"Nutr Diabetes"},{"issue":"1","key":"5379_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrendo.2015.189","volume":"12","author":"DE Lackey","year":"2016","unstructured":"Lackey DE, Olefsky JM (2016) Regulation of metabolism by the innate immune system. Nat Rev Endocrinol 12(1):15\u201328. https:\/\/doi.org\/10.1038\/nrendo.2015.189","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"5379_CR27","doi-asserted-by":"publisher","first-page":"e21216","DOI":"10.1096\/fj.202001147R","volume":"35","author":"D Pretz","year":"2021","unstructured":"Pretz D, Le Foll C, Rizwan MZ, Lutz TA, Tups A (2021) Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity. FASEB J 35(2):e21216. https:\/\/doi.org\/10.1096\/fj.202001147R","journal-title":"FASEB J"},{"issue":"3","key":"5379_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1523-1755.1999.00626.x","volume":"56","author":"G Wolf","year":"1999","unstructured":"Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA (1999) Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]. Kidney Int 56(3):860\u2013872. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00626.x","journal-title":"Kidney Int"},{"issue":"2","key":"5379_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/157340210791170994","volume":"6","author":"K Rahmouni","year":"2010","unstructured":"Rahmouni K (2010) Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev 6(2):104\u2013209. https:\/\/doi.org\/10.2174\/157340210791170994","journal-title":"Curr Hypertens Rev"},{"issue":"24","key":"5379_CR30","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1016\/j.lfs.2003.10.029","volume":"74","author":"J Beltowski","year":"2004","unstructured":"Beltowski J, W\u00f3jcicka G, Marciniak A, Jamroz A (2004) Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 74(24):2987\u20133000. https:\/\/doi.org\/10.1016\/j.lfs.2003.10.029","journal-title":"Life Sci"},{"issue":"1","key":"5379_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS (2022) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 46(1):15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"issue":"1","key":"5379_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93(1):137\u2013188. https:\/\/doi.org\/10.1152\/physrev.00045.2011","journal-title":"Physiol Rev"},{"issue":"6","key":"5379_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4239\/wjd.v5.i6.860","volume":"5","author":"J Zhao","year":"2014","unstructured":"Zhao J, Randive R, Stewart JA (2014) Molecular mechanisms of AGE\/RAGE-mediated fibrosis in the diabetic heart. World J Diabetes 5(6):860\u2013867. https:\/\/doi.org\/10.4239\/wjd.v5.i6.860","journal-title":"World J Diabetes"},{"issue":"3","key":"5379_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12(3):144\u2013153. https:\/\/doi.org\/10.1038\/nrendo.2015.216","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"5379_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1172\/JCI11771","volume":"108","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H (2001) Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108(2):261\u2013268. https:\/\/doi.org\/10.1172\/JCI11771","journal-title":"J Clin Invest"},{"issue":"12","key":"5379_CR36","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, Wada J (2022) Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metab 24(12):2283\u20132296. https:\/\/doi.org\/10.1111\/dom.14829","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"5379_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED (2021) Cardiac energy metabolism in heart failure. Circ Res 128(10):1487\u20131513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241","journal-title":"Circ Res"},{"issue":"12","key":"5379_CR38","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12(12):2032\u20132045. https:\/\/doi.org\/10.2215\/CJN.11491116","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"5379_CR39","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/ndt\/gfad052","volume":"38","author":"W Kriz","year":"2023","unstructured":"Kriz W, L\u00f6wen J, Gr\u00f6ne HJ (2023) The complex pathology of diabetic nephropathy in humans. Nephrol Dial Transplant 38(10):2109\u20132119. https:\/\/doi.org\/10.1093\/ndt\/gfad052","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"5379_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR (2018) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61(1):21\u201328. https:\/\/doi.org\/10.1007\/s00125-017-4390-4","journal-title":"Diabetologia"},{"issue":"12","key":"5379_CR41","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1210\/en.2009-0543","volume":"150","author":"M B\u00f6ni-Schnetzler","year":"2009","unstructured":"B\u00f6ni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY (2009) Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150(12):5218\u20135229. https:\/\/doi.org\/10.1210\/en.2009-0543","journal-title":"Endocrinology"},{"issue":"6","key":"5379_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI15318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110(6):851\u2013860. https:\/\/doi.org\/10.1172\/JCI15318","journal-title":"J Clin Invest"},{"issue":"11","key":"5379_CR43","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116(11):3015\u20133025. https:\/\/doi.org\/10.1172\/JCI28898","journal-title":"J Clin Invest"},{"issue":"2","key":"5379_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11(2):136\u2013140. https:\/\/doi.org\/10.1038\/ni.1831","journal-title":"Nat Immunol"},{"issue":"9","key":"5379_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11912-023-01426-0","volume":"25","author":"GS Prousi","year":"2023","unstructured":"Prousi GS, Joshi AM, Atti V, Addison D, Brown SA, Guha A, Patel B (2023) Vascular inflammation, cancer, and cardiovascular diseases. Curr Oncol Rep 25(9):955\u2013963. https:\/\/doi.org\/10.1007\/s11912-023-01426-0","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"5379_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","volume":"16","author":"SCW Tang","year":"2020","unstructured":"Tang SCW, Yiu WH (2020) Innate immunity in diabetic kidney disease. Nat Rev Nephrol 16(4):206\u2013222. https:\/\/doi.org\/10.1038\/s41581-019-0234-4","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"5379_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR (2020) Targeting the progression of chronic kidney disease. Nat Rev Nephrol 16(5):269\u2013288. https:\/\/doi.org\/10.1038\/s41581-019-0248-y","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5379_CR48","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311(6):F1087\u2013F1108. https:\/\/doi.org\/10.1152\/ajprenal.00340.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"5379_CR49","doi-asserted-by":"publisher","first-page":"117955141879225","DOI":"10.1177\/1179551418792257","volume":"1","author":"CE Kosmas","year":"2018","unstructured":"Kosmas CE, Silverio D, Tsomidou C, Salcedo MD, Montan PD, Guzman E (2018) The impact of insulin resistance and chronic kidney disease on inflammation and cardiovascular disease. Clin Med Insights Endocrinol Diabetes 1(11):1179551418792257. https:\/\/doi.org\/10.1177\/1179551418792257","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"12","key":"5379_CR50","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"J Gupta","year":"2012","unstructured":"Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS, CRIC Study Investigators (2012) Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7(12):1938\u20131946. https:\/\/doi.org\/10.2215\/CJN.03500412","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"5379_CR51","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, Roy-Chaudhury A, Go AS, Joffe M, He J, Balakrishnan VS, Kimmel PL, Kusek JW, Raj DS, CRIC Study Investigators (2016) Inflammation and progression of CKD: the CRIC study. Clin J Am Soc Nephrol 11(9):1546\u20131556. https:\/\/doi.org\/10.2215\/CJN.13121215","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"5379_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020404","volume":"9","author":"R Eiros","year":"2020","unstructured":"Eiros R, Romero-Gonz\u00e1lez G, Gavira JJ, Beloqui O, Colina I, Fort\u00fan Landecho M, L\u00f3pez B, Gonz\u00e1lez A, D\u00edez J, Ravassa S (2020) Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin? J Clin Med 9(2):404. https:\/\/doi.org\/10.3390\/jcm9020404","journal-title":"J Clin Med"},{"key":"5379_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000349972","volume":"182","author":"JA Tumlin","year":"2013","unstructured":"Tumlin JA, Costanzo MR, Chawla LS, Herzog CA, Kellum JA, McCullough PA, Ronco C (2013) Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:158\u2013173. https:\/\/doi.org\/10.1159\/000349972","journal-title":"Contrib Nephrol"},{"issue":"8","key":"5379_CR54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","volume":"17","author":"H Noels","year":"2021","unstructured":"Noels H, Lehrke M, Vanholder R, Jankowski J (2021) Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat Rev Nephrol 17(8):528\u2013542. https:\/\/doi.org\/10.1038\/s41581-021-00423-5","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5379_CR55","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","volume":"46","author":"W Doehner","year":"2005","unstructured":"Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD (2005) Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46(6):1019\u20131026. https:\/\/doi.org\/10.1016\/j.jacc.2005.02.093","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5379_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MA, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455\u2013469. https:\/\/doi.org\/10.1093\/eurheartj\/eht386","journal-title":"Eur Heart J"},{"issue":"2","key":"5379_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrneph.2012.279","volume":"9","author":"P Hatamizadeh","year":"2013","unstructured":"Hatamizadeh P, Fonarow GC, Budoff MJ, Darabian S, Kovesdy CP, Kalantar-Zadeh K (2013) Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol 9(2):99\u2013111. https:\/\/doi.org\/10.1038\/nrneph.2012.279","journal-title":"Nat Rev Nephrol"},{"issue":"6 Pt 1","key":"5379_CR58","doi-asserted-by":"publisher","first-page":"E763","DOI":"10.1152\/ajpendo.1992.262.6.E763","volume":"262","author":"IA Reid","year":"1992","unstructured":"Reid IA (1992) Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262(6 Pt 1):E763\u2013E778. https:\/\/doi.org\/10.1152\/ajpendo.1992.262.6.E763","journal-title":"Am J Physiol"},{"issue":"17","key":"5379_CR59","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","volume":"340","author":"G Ligtenberg","year":"1999","unstructured":"Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340(17):1321\u20131328. https:\/\/doi.org\/10.1056\/NEJM199904293401704","journal-title":"N Engl J Med"},{"issue":"8","key":"5379_CR60","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms18081682","volume":"18","author":"J Kaur","year":"2017","unstructured":"Kaur J, Young BE, Fadel PJ (2017) Sympathetic overactivity in chronic kidney disease: consequences and mechanisms. Int J Mol Sci 18(8):1682. https:\/\/doi.org\/10.3390\/ijms18081682","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5379_CR61","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier M, Damianaki A (2023) Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res 132(8):1050\u20131063. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321762","journal-title":"Circ Res"},{"issue":"Pt 20","key":"5379_CR62","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1113\/jphysiol.2009.177204","volume":"587","author":"CN Young","year":"2009","unstructured":"Young CN, Fisher JP, Gallagher KM, Whaley-Connell A, Chaudhary K, Victor RG, Thomas GD, Fadel PJ (2009) Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans. J Physiol 587(Pt 20):4977\u20134986. https:\/\/doi.org\/10.1113\/jphysiol.2009.177204","journal-title":"J Physiol"},{"issue":"22","key":"5379_CR63","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/s0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Bode-B\u00f6ger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Fr\u00f6lich J, B\u00f6ger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358(22):2113\u20132117. https:\/\/doi.org\/10.1016\/s0140-6736(01)07217-8","journal-title":"Lancet"},{"issue":"6","key":"5379_CR64","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2215\/CJN.06671208","volume":"4","author":"JM Young","year":"2009","unstructured":"Young JM, Terrin N, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Sarnak MJ, Menon V (2009) Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol 4(6):1115\u20131120. https:\/\/doi.org\/10.2215\/CJN.06671208","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"5379_CR65","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1681\/ASN.2005010076","volume":"16","author":"P Ravani","year":"2005","unstructured":"Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C (2005) Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16(8):2449\u20132455. https:\/\/doi.org\/10.1681\/ASN.2005010076","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5379_CR66","first-page":"181","volume":"103","author":"RG Gerrity","year":"1981","unstructured":"Gerrity RG (1981) The role of the monocyte in atherogenesis: I. transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103(2):181\u2013190","journal-title":"Am J Pathol"},{"issue":"7293","key":"5379_CR67","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357\u20131361. https:\/\/doi.org\/10.1038\/nature08938","journal-title":"Nature"},{"key":"5379_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176338","volume":"966","author":"A Attiq","year":"2024","unstructured":"Attiq A, Afzal S, Ahmad W, Kandeel M (2024) Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol 966:176338. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176338","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5379_CR69","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ki.2012.406","volume":"83","author":"JF Gnanaraj","year":"2013","unstructured":"Gnanaraj JF et al (2013) The relevance of congestion in the cardio-renal syndrome. Kidney Int 83(3):384\u2013391. https:\/\/doi.org\/10.1038\/ki.2012.406","journal-title":"Kidney Int"},{"issue":"7","key":"5379_CR70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WHW (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589\u2013596. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.068","journal-title":"J Am Coll Cardiol"},{"issue":"7203","key":"5379_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428\u2013435. https:\/\/doi.org\/10.1038\/nature07201","journal-title":"Nature"},{"issue":"1","key":"5379_CR72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/ijms24010641","volume":"24","author":"AM Soliman","year":"2022","unstructured":"Soliman AM, Barreda DR (2022) Acute inflammation in tissue healing. Int J Mol Sci 24(1):641. https:\/\/doi.org\/10.3390\/ijms24010641","journal-title":"Int J Mol Sci"},{"key":"5379_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.946832","volume":"13","author":"JH Wen","year":"2022","unstructured":"Wen JH, Li DY, Liang S, Yang C, Tang JX, Liu HF (2022) Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis. Front Immunol 13:946832. https:\/\/doi.org\/10.3389\/fimmu.2022.946832","journal-title":"Front Immunol"},{"issue":"4","key":"5379_CR74","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10753-018-0739-1","volume":"41","author":"ML Varela","year":"2018","unstructured":"Varela ML, Mogildea M, Moreno I, Lopes A (2018) Acute inflammation and metabolism. Inflammation 41(4):1115\u20131127. https:\/\/doi.org\/10.1007\/s10753-018-0739-1","journal-title":"Inflammation"},{"issue":"4","key":"5379_CR75","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"YJ Lin","year":"2020","unstructured":"Lin YJ, Anzaghe M, Sch\u00fclke S (2020) Update on the pathomechanism, diagnosis, and treatment options for Rheumatoid Arthritis. Cells 9(4):880. https:\/\/doi.org\/10.3390\/cells9040880","journal-title":"Cells"},{"issue":"17","key":"5379_CR76","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR (2024) Systemic lupus erythematosus: a review. JAMA 331(17):1480\u20131491. https:\/\/doi.org\/10.1001\/jama.2024.2315","journal-title":"JAMA"},{"issue":"19","key":"5379_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193001","volume":"11","author":"H Li","year":"2022","unstructured":"Li H, Meng Y, He S, Tan X, Zhang Y, Zhang X, Wang L, Zheng W (2022) Macrophages, chronic inflammation, and insulin resistance. Cells 11(19):3001. https:\/\/doi.org\/10.3390\/cells11193001","journal-title":"Cells"},{"issue":"3","key":"5379_CR78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.kint.2024.03.033","volume":"106","author":"AL Corken","year":"2024","unstructured":"Corken AL, Ong V, Kore R, Ghanta SN, Karaduta O, Pathak R, Rose S, Porter C, Jain N (2024) Platelets, inflammation, and purinergic receptors in chronic kidney disease. Kidney Int 106(3):392\u2013399. https:\/\/doi.org\/10.1016\/j.kint.2024.03.033","journal-title":"Kidney Int"},{"issue":"21","key":"5379_CR79","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","volume":"23","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F (2022) The role of inflammation in cardiovascular disease. Int J Mol Sci 23(21):12906. https:\/\/doi.org\/10.3390\/ijms232112906","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5379_CR80","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822\u20131832. https:\/\/doi.org\/10.1038\/s41591-019-0675-0","journal-title":"Nat Med"},{"key":"5379_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exger.2017.12.015","volume":"105","author":"A Bektas","year":"2018","unstructured":"Bektas A, Schurman SH, Sen R, Ferrucci L (2018) Aging, inflammation and the environment. Exp Gerontol 105:10\u201318. https:\/\/doi.org\/10.1016\/j.exger.2017.12.015","journal-title":"Exp Gerontol"},{"key":"5379_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2016.11.013","volume":"808","author":"M Taghavi","year":"2017","unstructured":"Taghavi M, Khosravi A, Mortaz E, Nikaein D, Athari SS (2017) Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections. Eur J Pharmacol 808:8\u201313. https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.013","journal-title":"Eur J Pharmacol"},{"key":"5379_CR83","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","volume":"206","author":"M Zhou","year":"2024","unstructured":"Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, Wu Q (2024) Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions\u2014a review. Pharmacol Res 206:107282. https:\/\/doi.org\/10.1016\/j.phrs.2024.107282","journal-title":"Pharmacol Res"},{"issue":"3","key":"5379_CR84","first-page":"78","volume":"28","author":"M Litwiniuk","year":"2016","unstructured":"Litwiniuk M, Krejner A, Speyrer MS, Gauto AR, Grzela T (2016) Hyaluronic acid in inflammation and tissue regeneration. Wounds 28(3):78\u201388","journal-title":"Wounds"},{"issue":"1","key":"5379_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11064-020-03208-7","volume":"46","author":"A Tauffenberger","year":"2021","unstructured":"Tauffenberger A, Magistretti PJ (2021) Reactive oxygen species: beyond their reactive behavior. Neurochem Res 46(1):77\u201387. https:\/\/doi.org\/10.1007\/s11064-020-03208-7","journal-title":"Neurochem Res"},{"issue":"6","key":"5379_CR86","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820. https:\/\/doi.org\/10.1016\/j.cell.2010.01.022","journal-title":"Cell"},{"issue":"1","key":"5379_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0.PMID:34344870","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6(1):291. https:\/\/doi.org\/10.1038\/s41392-021-00687-0.PMID:34344870","journal-title":"Signal Transduct Target Ther"},{"issue":"5963","key":"5379_CR88","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327(5963):296\u2013300. https:\/\/doi.org\/10.1126\/science.1184003","journal-title":"Science"},{"issue":"9","key":"5379_CR89","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat Rev Immunol"},{"issue":"2018","key":"5379_CR90","doi-asserted-by":"publisher","first-page":"9524075","DOI":"10.1155\/2018\/9524075","volume":"27","author":"ACCC Branco","year":"2018","unstructured":"Branco ACCC, Yoshikawa FSY, Pietrobon AJ, Sato MN (2018) Role of histamine in modulating the immune response and inflammation. Mediat Inflamm 27(2018):9524075. https:\/\/doi.org\/10.1155\/2018\/9524075","journal-title":"Mediat Inflamm"},{"issue":"22","key":"5379_CR91","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","volume":"73","author":"A Mashaghi","year":"2016","unstructured":"Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R (2016) Neuropeptide substance P and the immune response. Cell Mol Life Sci 73(22):4249\u20134264. https:\/\/doi.org\/10.1007\/s00018-016-2293-z","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"5379_CR92","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1159\/000538241","volume":"148","author":"S Buelli","year":"2024","unstructured":"Buelli S, Imberti B, Morigi M (2024) The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation. Nephron 148(10):712\u2013723. https:\/\/doi.org\/10.1159\/000538241","journal-title":"Nephron"},{"issue":"4","key":"5379_CR93","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07","volume":"1851","author":"K Kawahara","year":"2015","unstructured":"Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y (2015) Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta 1851(4):414\u2013421. https:\/\/doi.org\/10.1016\/j.bbalip.2014.07","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5379_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010075","volume":"10","author":"M Lagan\u00e0","year":"2021","unstructured":"Lagan\u00e0 M, Schlecht-Louf G, Bachelerie F (2021) The G protein-coupled receptor kinases (GRKs) in chemokine receptor-mediated immune cell migration: from molecular cues to physiopathology. Cells 10(1):75. https:\/\/doi.org\/10.3390\/cells10010075","journal-title":"Cells"},{"issue":"4","key":"5379_CR95","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5606\/ArchRheumatol.2018.6595","volume":"33","author":"S Gao","year":"2018","unstructured":"Gao S, Zhu H, Zuo X, Luo H (2018) Cathepsin G and its role in inflammation and autoimmune diseases. Arch Rheumatol 33(4):498\u2013504. https:\/\/doi.org\/10.5606\/ArchRheumatol.2018.6595","journal-title":"Arch Rheumatol"},{"issue":"12","key":"5379_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121935","volume":"11","author":"KEM Hellenthal","year":"2022","unstructured":"Hellenthal KEM, Brabenec L, Wagner NM (2022) Regulation and dysregulation of endothelial permeability during systemic inflammation. Cells 11(12):1935. https:\/\/doi.org\/10.3390\/cells11121935","journal-title":"Cells"},{"issue":"19","key":"5379_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cells11192953","volume":"11","author":"A Hassanshahi","year":"2022","unstructured":"Hassanshahi A, Moradzad M, Ghalamkari S, Fadaei M, Cowin AJ, Hassanshahi M (2022) Macrophage-mediated inflammation in skin wound healing. Cells 11(19):2953. https:\/\/doi.org\/10.3390\/cells11192953","journal-title":"Cells"},{"issue":"3","key":"5379_CR98","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159\u2013175. https:\/\/doi.org\/10.1038\/nri3399","journal-title":"Nat Rev Immunol"},{"issue":"Feb 14","key":"5379_CR99","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy S, Rudensky AY (2023) Principles of regulatory T cell function. Immunity 56(Feb 14):240\u2013255. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.004","journal-title":"Immunity"},{"issue":"9","key":"5379_CR100","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece D, Verzella D, Flati I, Arboretto P, Cornice J, Franzoso G (2022) NF-\u03baB: blending metabolism, immunity, and inflammation. Trends Immunol 43(9):757\u2013775. https:\/\/doi.org\/10.1016\/j.it.2022.07.004","journal-title":"Trends Immunol"},{"issue":"1","key":"5379_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA (2013) The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer 12(1):86. https:\/\/doi.org\/10.1186\/1476-4598-12-86","journal-title":"Mol Cancer"},{"issue":"6706","key":"5379_CR102","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396(6706):77\u201380. https:\/\/doi.org\/10.1038\/23948","journal-title":"Nature"},{"issue":"1","key":"5379_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2(1):17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5379_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"5379_CR105","doi-asserted-by":"publisher","first-page":"a006049","DOI":"10.1101\/cshperspect.a006049","volume":"4","author":"K Newton","year":"2012","unstructured":"Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4(3):a006049. https:\/\/doi.org\/10.1101\/cshperspect.a006049","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"5379_CR106","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240\u2013273. https:\/\/doi.org\/10.1128\/CMR.00046-08","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"5379_CR107","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","volume":"34","author":"SC Sun","year":"2013","unstructured":"Sun SC, Chang JH, Jin J (2013) Regulation of nuclear factor-\u03baB in autoimmunity. Trends Immunol 34(6):282\u2013289. https:\/\/doi.org\/10.1016\/j.it.2013.01.004","journal-title":"Trends Immunol"},{"issue":"2","key":"5379_CR108","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S (2011) NF-\u03baB in immunobiology. Cell Res 21(2):223\u2013244. https:\/\/doi.org\/10.1038\/cr.2011.13","journal-title":"Cell Res"},{"key":"5379_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C (2020) Macrophage M1\/M2 polarization. Eur J Pharmacol 877:173090. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173090","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"5379_CR110","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"28","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage m1\u2013m2 polarization balance. Front Immunol 28(5):614. https:\/\/doi.org\/10.3389\/fimmu.2014.00614","journal-title":"Front Immunol"},{"issue":"1","key":"5379_CR111","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/db06-1076","volume":"56","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR (2007) Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56(1):16\u201323. https:\/\/doi.org\/10.2337\/db06-1076","journal-title":"Diabetes"},{"issue":"1","key":"5379_CR112","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175\u2013184. https:\/\/doi.org\/10.1172\/JCI29881","journal-title":"J Clin Invest"},{"issue":"8","key":"5379_CR113","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8):914\u2013920. https:\/\/doi.org\/10.1038\/nm.1964","journal-title":"Nat Med"},{"issue":"1","key":"5379_CR114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21623945.2021.1965314","volume":"10","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang Y, Xu D (2021) The roles of T cells in obese adipose tissue inflammation. Adipocyte 10(1):435\u2013445. https:\/\/doi.org\/10.1080\/21623945.2021.1965314","journal-title":"Adipocyte"},{"issue":"1","key":"5379_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01659-x","volume":"11","author":"JT Ahrendsen","year":"2023","unstructured":"Ahrendsen JT, Nong Y, Huo Y, Steele J, Anderson MP (2023) CD8 cytotoxic T-cell infiltrates and cellular damage in the hypothalamus in human obesity. Acta Neuropathol Commun 11(1):163. https:\/\/doi.org\/10.1186\/s40478-023-01659-x","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"5379_CR116","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.111.090134","volume":"125","author":"JK Kim","year":"2012","unstructured":"Kim JK (2012) Endothelial nuclear factor \u03baB in obesity and aging: is endothelial nuclear factor \u03baB a master regulator of inflammation and insulin resistance? Circulation 125(9):1081\u20131083. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.090134","journal-title":"Circulation"},{"issue":"1","key":"5379_CR117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S (2011) NF-\u03baB, inflammation, and metabolic disease. Cell Metab 13(1):11\u201322. https:\/\/doi.org\/10.1016\/j.cmet.2010.12.008","journal-title":"Cell Metab"},{"issue":"2\u20133","key":"5379_CR118","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1385\/ENDO:23:2-3:177","volume":"23","author":"SE Borst","year":"2004","unstructured":"Borst SE (2004) The role of TNF-alpha in insulin resistance. Endocrine 23(2\u20133):177\u2013182. https:\/\/doi.org\/10.1385\/ENDO:23:2-3:177","journal-title":"Endocrine"},{"issue":"1","key":"5379_CR119","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A (2018) Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem 119(1):105\u2013110. https:\/\/doi.org\/10.1002\/jcb.26174","journal-title":"J Cell Biochem"},{"issue":"3","key":"5379_CR120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201416","volume":"218","author":"F He","year":"2021","unstructured":"He F, Huang Y, Song Z, Zhou HJ, Zhang H, Perry RJ, Shulman GI, Min W (2021) Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance. J Exp Med 218(3):e20201416. https:\/\/doi.org\/10.1084\/jem.20201416","journal-title":"J Exp Med"},{"issue":"7","key":"5379_CR121","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1507\/endocrj.EJ17-0012","volume":"64","author":"F Xie","year":"2017","unstructured":"Xie F, Zhu J, Hou B, Wang Y, Meng F, Ren Z, Ren S (2017) Inhibition of NF-\u03baB activation improves insulin resistance of L6 cells. Endocr J 64(7):685\u2013693. https:\/\/doi.org\/10.1507\/endocrj.EJ17-0012","journal-title":"Endocr J"},{"issue":"9","key":"5379_CR122","doi-asserted-by":"publisher","first-page":"R1144","DOI":"10.1152\/ajpregu.00442.2014","volume":"309","author":"TJ Cyphert","year":"2015","unstructured":"Cyphert TJ, Morris RT, House LM, Barnes TM, Otero YF, Barham WJ, Hunt RP, Zaynagetdinov R, Yull FE, Blackwell TS, McGuinness OP (2015) NF-\u03baB-dependent airway inflammation triggers systemic insulin resistance. Am J Physiol Regul Integr Comp Physiol 309(9):R1144\u2013R1152. https:\/\/doi.org\/10.1152\/ajpregu.00442.2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"5379_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7(1):182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"5379_CR124","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM Tang","year":"2019","unstructured":"Tang PM, Nikolic-Paterson DJ, Lan HY (2019) Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol 15(3):144\u2013158. https:\/\/doi.org\/10.1038\/s41581-019-0110-2","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"5379_CR125","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1681\/ASN.2019020111","volume":"30","author":"Y Wen","year":"2019","unstructured":"Wen Y, Lu X, Ren J, Privratsky JR, Yang B, Rudemiller NP, Zhang J, Griffiths R, Jain MK, Nedospasov SA, Liu BC, Crowley SD (2019) KLF4 in macrophages attenuates TNF\u03b1-mediated kidney injury and fibrosis. J Am Soc Nephrol 30(10):1925\u20131938. https:\/\/doi.org\/10.1681\/ASN.2019020111","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5379_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04577-3","volume":"13","author":"K Ai","year":"2022","unstructured":"Ai K, Pan J, Zhang P, Li H, He Z, Zhang H, Li X, Li Y, Yi L, Kang Y, Wang Y, Xiang X, Chai X, Zhang D (2022) Methyl-CpG-binding domain protein 2 contributes to renal fibrosis through promoting polarized M1 macrophages. Cell Death Dis 13(2):125. https:\/\/doi.org\/10.1038\/s41419-022-04577-3","journal-title":"Cell Death Dis"},{"issue":"4","key":"5379_CR127","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ki.2010.177","volume":"78","author":"TT Tapmeier","year":"2010","unstructured":"Tapmeier TT, Fearn A, Brown K, Chowdhury P, Sacks SH, Sheerin NS, Wong W (2010) Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 78(4):351\u2013362. https:\/\/doi.org\/10.1038\/ki.2010.177","journal-title":"Kidney Int"},{"issue":"4","key":"5379_CR128","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000343283","volume":"36","author":"L Liu","year":"2012","unstructured":"Liu L, Kou P, Zeng Q, Pei G, Li Y, Liang H, Xu G, Chen S (2012) CD4+ T lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis. Am J Nephrol 36(4):386\u2013396. https:\/\/doi.org\/10.1159\/000343283","journal-title":"Am J Nephrol"},{"issue":"8","key":"5379_CR129","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1172\/JCI97879","volume":"128","author":"A Chen","year":"2018","unstructured":"Chen A, Lee K, D\u2019Agati VD, Wei C, Fu J, Guan TJ, He JC, Schlondorff D, Agudo J (2018) Bowman\u2019s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J Clin Invest 128(8):3413\u20133424. https:\/\/doi.org\/10.1172\/JCI97879","journal-title":"J Clin Invest"},{"issue":"7","key":"5379_CR130","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1172\/JCI90921","volume":"127","author":"LX Li","year":"2017","unstructured":"Li LX, Fan LX, Zhou JX, Grantham JJ, Calvet JP, Sage J, Li X (2017) Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. J Clin Invest 127(7):2751\u20132764. https:\/\/doi.org\/10.1172\/JCI90921","journal-title":"J Clin Invest"},{"key":"5379_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00447","volume":"4","author":"J Poveda","year":"2013","unstructured":"Poveda J, Tabara LC, Fernandez-Fernandez B, Martin-Cleary C, Sanz AB, Selgas R, Ortiz A, Sanchez-Ni\u00f1o MD (2013) TWEAK\/Fn14 and non-canonical NF-kappaB signaling in kidney disease. Front Immunol 4:447. https:\/\/doi.org\/10.3389\/fimmu.2013.00447","journal-title":"Front Immunol"},{"key":"5379_CR132","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Wang Y, Fan F, Roman RJ (2018) Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol 820:65\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.016","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"5379_CR133","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2020071094","volume":"32","author":"A Cordido","year":"2021","unstructured":"Cordido A, Nu\u00f1ez-Gonzalez L, Martinez-Moreno JM, Lamas-Gonzalez O, Rodriguez-Osorio L, Perez-Gomez MV, Martin-Sanchez D, Outeda P, Chiaravalli M, Watnick T, Boletta A, Diaz C, Carracedo A, Sanz AB, Ortiz A, Garcia-Gonzalez MA (2021) TWEAK signaling pathway blockade slows cyst growth and disease progression in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 32(8):1913\u20131932. https:\/\/doi.org\/10.1681\/ASN.2020071094","journal-title":"J Am Soc Nephrol"},{"key":"5379_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111254","volume":"529","author":"E Cantero-Navarro","year":"2021","unstructured":"Cantero-Navarro E, Fern\u00e1ndez-Fern\u00e1ndez B, Ramos AM, Rayego-Mateos S, Rodrigues-Diez RR, S\u00e1nchez-Ni\u00f1o MD, Sanz AB, Ruiz-Ortega M, Ortiz A (2021) Renin-angiotensin system and inflammation update. Mol Cell Endocrinol 529:111254. https:\/\/doi.org\/10.1016\/j.mce.2021.111254","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"5379_CR135","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","volume":"106","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, Li Y, Luo D, Wu K, Xu Y, Li G, Zhou Y, Zhou Y, Chen W, Liu Q, Mao H (2024) The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-\u03baB family activation. Kidney Int 106(2):226\u2013240. https:\/\/doi.org\/10.1016\/j.kint.2024.04.016","journal-title":"Kidney Int"},{"issue":"4","key":"5379_CR136","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2904161","volume":"29","author":"B Yan","year":"2024","unstructured":"Yan B, Yu X, Cai X, Huang X, Xie B, Lian D, Chen J, Li W, Lin Y, Ye J, Li J (2024) A review: the significance of Toll-like receptors 2 and 4, and NF-\u03baB signaling in endothelial cells during atherosclerosis. Front Biosci (Landmark Ed) 29(4):161. https:\/\/doi.org\/10.31083\/j.fbl2904161","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"7","key":"5379_CR137","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1172\/JCI118598","volume":"97","author":"K Brand","year":"1996","unstructured":"Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97(7):1715\u20131722. https:\/\/doi.org\/10.1172\/JCI118598","journal-title":"J Clin Invest"},{"issue":"1","key":"5379_CR138","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2010.179","volume":"21","author":"S Miyamoto","year":"2011","unstructured":"Miyamoto S (2011) Nuclear initiated NF-\u03baB signaling: NEMO and ATM take center stage. Cell Res 21(1):116\u2013130. https:\/\/doi.org\/10.1038\/cr.2010.179","journal-title":"Cell Res"},{"issue":"5","key":"5379_CR139","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmet.2008.08.016","volume":"8","author":"R Gareus","year":"2008","unstructured":"Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M (2008) Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 8(5):372\u2013383. https:\/\/doi.org\/10.1016\/j.cmet.2008.08.016","journal-title":"Cell Metab"},{"issue":"1","key":"5379_CR140","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119(1):91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577","journal-title":"Circ Res"},{"issue":"1","key":"5379_CR141","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/13880209.2021.1878236","volume":"59","author":"W Quan","year":"2021","unstructured":"Quan W, Liu HX, Zhang W, Lou WJ, Gong YZ, Yuan C, Shao Q, Wang N, Guo C, Liu F (2021) Cardioprotective effect of rosmarinic acid against myocardial ischaemia\/reperfusion injury via suppression of the NF-\u03baB inflammatory signalling pathway and ROS production in mice. Pharm Biol 59(1):222\u2013231. https:\/\/doi.org\/10.1080\/13880209.2021.1878236","journal-title":"Pharm Biol"},{"issue":"3","key":"5379_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166997","volume":"1870","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang S, Liu H, Gao L, He L, Chen Y, Zhang J, Yang M, He C (2024) Sting activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-\u03baB-mediated inflammatory response. Biochim Biophys Acta Mol Basis Dis 1870(3):166997. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166997","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5307","key":"5379_CR143","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma. Science 275(5307):1784\u20131787. https:\/\/doi.org\/10.1126\/science.275.5307.1784","journal-title":"Science"},{"issue":"2","key":"5379_CR144","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s40200-021-00862-8","volume":"20","author":"B Das","year":"2021","unstructured":"Das B, Das M, Kalita A, Baro MR (2021) The role of Wnt pathway in obesity induced inflammation and diabetes: a review. J Diabetes Metab Disord 20(2):1871\u20131882. https:\/\/doi.org\/10.1007\/s40200-021-00862-8","journal-title":"J Diabetes Metab Disord"},{"issue":"6","key":"5379_CR145","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat R, Manzoor M, Hussain A (2022) Wnt signaling pathway: a comprehensive review. Cell Biol Int 46(6):863\u2013877. https:\/\/doi.org\/10.1002\/cbin.11797","journal-title":"Cell Biol Int"},{"issue":"15","key":"5379_CR146","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","volume":"360","author":"AM Cypess","year":"2009","unstructured":"Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360(15):1509\u20131517. https:\/\/doi.org\/10.1056\/NEJMoa0810780","journal-title":"N Engl J Med"},{"issue":"5","key":"5379_CR147","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nm.3112","volume":"19","author":"AM Cypess","year":"2013","unstructured":"Cypess AM, White AP, Vernochet C, Schulz TJ, Xue R, Sass CA, Huang TL, Roberts-Toler C, Weiner LS, Sze C, Chacko AT, Deschamps LN, Herder LM, Truchan N, Glasgow AL, Holman AR, Gavrila A, Hasselgren PO, Mori MA, Molla M, Tseng YH (2013) Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med 19(5):635\u2013639. https:\/\/doi.org\/10.1038\/nm.3112","journal-title":"Nat Med"},{"issue":"12","key":"5379_CR148","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.2337\/db14-0746","volume":"63","author":"M Chondronikola","year":"2014","unstructured":"Chondronikola M, Volpi E, B\u00f8rsheim E, Porter C, Annamalai P, Enerb\u00e4ck S, Lidell ME, Saraf MK, Labbe SM, Hurren NM, Yfanti C, Chao T, Andersen CR, Cesani F, Hawkins H, Sidossis LS (2014) Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 63(12):4089\u20134099. https:\/\/doi.org\/10.2337\/db14-0746","journal-title":"Diabetes"},{"issue":"5481","key":"5379_CR149","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.289.5481.950","volume":"289","author":"SE Ross","year":"2000","unstructured":"Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA (2000) Inhibition of adipogenesis by Wnt signaling. Science 289(5481):950\u2013953. https:\/\/doi.org\/10.1126\/science.289.5481.950","journal-title":"Science"},{"issue":"Pt 3","key":"5379_CR150","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/BJ20030426","volume":"376","author":"M Moldes","year":"2003","unstructured":"Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR (2003) Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis. Biochem J 376(Pt 3):607\u2013613. https:\/\/doi.org\/10.1042\/BJ20030426","journal-title":"Biochem J"},{"issue":"1","key":"5379_CR151","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbrc.2009.07.004","volume":"387","author":"FH van Tienen","year":"2009","unstructured":"van Tienen FH, Laeremans H, van der Kallen CJ, Smeets HJ (2009) Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a. Biochem Biophys Res Commun 387(1):207\u2013211. https:\/\/doi.org\/10.1016\/j.bbrc.2009.07.004","journal-title":"Biochem Biophys Res Commun"},{"issue":"21\u201322","key":"5379_CR152","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.febslet.2008.08.011","volume":"582","author":"M Nishizuka","year":"2008","unstructured":"Nishizuka M, Koyanagi A, Osada S, Imagawa M (2008) Wnt4 and Wnt5a promote adipocyte differentiation. FEBS Lett 582(21\u201322):3201\u20133205. https:\/\/doi.org\/10.1016\/j.febslet.2008.08.011","journal-title":"FEBS Lett"},{"issue":"4","key":"5379_CR153","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.cmet.2012.03.010","volume":"15","author":"D Zeve","year":"2012","unstructured":"Zeve D, Seo J, Suh JM, Stenesen D, Tang W, Berglund ED, Wan Y, Williams LJ, Lim A, Martinez MJ, McKay RM, Millay DP, Olson EN, Graff JM (2012) Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metab 15(4):492\u2013504. https:\/\/doi.org\/10.1016\/j.cmet.2012.03.010","journal-title":"Cell Metab"},{"issue":"12","key":"5379_CR154","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/ncb2867","volume":"15","author":"J Wang","year":"2013","unstructured":"Wang J, Liu R, Wang F, Hong J, Li X, Chen M, Ke Y, Zhang X, Ma Q, Wang R, Shi J, Cui B, Gu W, Zhang Y, Zhang Z, Wang W, Xia X, Liu M, Ning G (2013) Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch. Nat Cell Biol 15(12):1455\u20131463. https:\/\/doi.org\/10.1038\/ncb2867","journal-title":"Nat Cell Biol"},{"issue":"7450","key":"5379_CR155","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature12124","volume":"497","author":"U Styrkarsdottir","year":"2013","unstructured":"Styrkarsdottir U, Thorleifsson G, Sulem P, Gudbjartsson DF, Sigurdsson A, Jonasdottir A, Jonasdottir A, Oddsson A, Helgason A, Magnusson OT, Walters GB, Frigge ML, Helgadottir HT, Johannsdottir H, Bergsteinsdottir K, Ogmundsdottir MH, Center JR, Nguyen TV, Eisman JA, Christiansen C, Steingrimsson E, Jonasson JG, Tryggvadottir L, Eyjolfsson GI, Theodors A, Jonsson T, Ingvarsson T, Olafsson I, Rafnar T, Kong A, Sigurdsson G, Masson G, Thorsteinsdottir U, Stefansson K (2013) Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497(7450):517\u2013520. https:\/\/doi.org\/10.1038\/nature12124","journal-title":"Nature"},{"issue":"6","key":"5379_CR156","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10815-010-9404-9","volume":"27","author":"SK Achrekar","year":"2010","unstructured":"Achrekar SK, Modi DN, Meherji PK, Patel ZM, Mahale SD (2010) Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. J Assist Reprod Genet 27(6):317\u2013326. https:\/\/doi.org\/10.1007\/s10815-010-9404-9","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"5379_CR157","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/nm.3324","volume":"19","author":"QA Wang","year":"2013","unstructured":"Wang QA, Tao C, Gupta RK, Scherer PE (2013) Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 19(10):1338\u20131344. https:\/\/doi.org\/10.1038\/nm.3324","journal-title":"Nat Med"},{"issue":"2","key":"5379_CR158","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrg2042","volume":"8","author":"JR Seifert","year":"2007","unstructured":"Seifert JR, Mlodzik M (2007) Frizzled\/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 8(2):126\u2013138. https:\/\/doi.org\/10.1038\/nrg2042","journal-title":"Nat Rev Genet"},{"issue":"5990","key":"5379_CR159","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1126\/science.1188280","volume":"329","author":"N Ouchi","year":"2010","unstructured":"Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, Akasaki Y, Shimono A, Walsh K (2010) Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329(5990):454\u2013457. https:\/\/doi.org\/10.1126\/science.1188280","journal-title":"Science"},{"issue":"4","key":"5379_CR160","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/db14-1164","volume":"64","author":"JJ Fuster","year":"2015","unstructured":"Fuster JJ, Zuriaga MA, Ngo DT, Farb MG, Aprahamian T, Yamaguchi TP, Gokce N, Walsh K (2015) Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 64(4):1235\u20131248. https:\/\/doi.org\/10.2337\/db14-1164","journal-title":"Diabetes"},{"issue":"1","key":"5379_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17509-5","volume":"7","author":"MA Zuriaga","year":"2017","unstructured":"Zuriaga MA, Fuster JJ, Farb MG, MacLauchlan S, Bret\u00f3n-Romero R, Karki S, Hess DT, Apovian CM, Hamburg NM, Gokce N, Walsh K (2017) Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation. Sci Rep 7(1):17326. https:\/\/doi.org\/10.1038\/s41598-017-17509-5","journal-title":"Sci Rep"},{"issue":"1","key":"5379_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083819","volume":"9","author":"F Tian","year":"2014","unstructured":"Tian F, Zhang YJ, Li Y, Xie Y (2014) Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. PLoS ONE 9(1):e83819. https:\/\/doi.org\/10.1371\/journal.pone.0083819","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"5379_CR163","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0168-8227(11)70008-0","volume":"93","author":"SA Sch\u00e4fer","year":"2011","unstructured":"Sch\u00e4fer SA, Machicao F, Fritsche A, H\u00e4ring HU, Kantartzis K (2011) New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract 93(Suppl 1):S9-24. https:\/\/doi.org\/10.1016\/S0168-8227(11)70008-0","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"5379_CR164","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/hep.22659","volume":"49","author":"G Musso","year":"2009","unstructured":"Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M (2009) Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 49(2):426\u2013435. https:\/\/doi.org\/10.1002\/hep.22659","journal-title":"Hepatology"},{"issue":"1","key":"5379_CR165","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2013.09.003","volume":"382","author":"X Wang","year":"2014","unstructured":"Wang X, Lei XG, Wang J (2014) Malondialdehyde regulates glucose-stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway. Mol Cell Endocrinol 382(1):8\u201316. https:\/\/doi.org\/10.1016\/j.mce.2013.09.003","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"5379_CR166","doi-asserted-by":"publisher","first-page":"E245","DOI":"10.1152\/ajpendo.00538.2009","volume":"298","author":"F Figeac","year":"2010","unstructured":"Figeac F, Uzan B, Faro M, Chelali N, Portha B, Movassat J (2010) Neonatal growth and regeneration of beta-cells are regulated by the Wnt\/beta-catenin signaling in normal and diabetic rats. Am J Physiol Endocrinol Metab 298(2):E245\u2013E256. https:\/\/doi.org\/10.1152\/ajpendo.00538.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"5379_CR167","first-page":"1123","volume":"46","author":"VA Potapov","year":"2010","unstructured":"Potapov VA, Shamkhalova MN, Smetanina SA, Bel\u2019chikova LN, Suplotova LA, Shestakova MV, Nosikov VV (2010) Polymorphic markers TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population. Genetika 46(8):1123\u20131131","journal-title":"Genetika"},{"key":"5379_CR168","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.metabol.2016.11.018","volume":"68","author":"J Lu","year":"2017","unstructured":"Lu J, Varghese RT, Zhou L, Vella A, Jensen MD (2017) Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146. Metabolism 68:55\u201363. https:\/\/doi.org\/10.1016\/j.metabol.2016.11.018","journal-title":"Metabolism"},{"issue":"7","key":"5379_CR169","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2016.54","volume":"12","author":"M Edeling","year":"2016","unstructured":"Edeling M, Ragi G, Huang S, Pavenst\u00e4dt H, Susztak K (2016) Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol 12(7):426\u2013439. https:\/\/doi.org\/10.1038\/nrneph.2016.54","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5379_CR170","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1152\/ajprenal.00136.2016","volume":"311","author":"H Beaton","year":"2016","unstructured":"Beaton H, Andrews D, Parsons M, Murphy M, Gaffney A, Kavanagh D, McKay GJ, Maxwell AP, Taylor CT, Cummins EP, Godson C, Higgins DF, Murphy P, Crean J (2016) Wnt6 regulates epithelial cell differentiation and is dysregulated in renal fibrosis. Am J Physiol Renal Physiol 311(1):F35-45. https:\/\/doi.org\/10.1152\/ajprenal.00136.2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"5379_CR171","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ki.2012.173","volume":"82","author":"D Zhou","year":"2012","unstructured":"Zhou D, Li Y, Lin L, Zhou L, Igarashi P, Liu Y (2012) Tubule-specific ablation of endogenous \u03b2-catenin aggravates acute kidney injury in mice. Kidney Int 82(5):537\u2013547. https:\/\/doi.org\/10.1038\/ki.2012.173","journal-title":"Kidney Int"},{"issue":"9","key":"5379_CR172","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1681\/ASN.2009030253","volume":"20","author":"Z Wang","year":"2009","unstructured":"Wang Z, Havasi A, Gall JM, Mao H, Schwartz JH, Borkan SC (2009) Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. J Am Soc Nephrol 20(9):1919\u20131928. https:\/\/doi.org\/10.1681\/ASN.2009030253","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5379_CR173","doi-asserted-by":"publisher","first-page":"F703","DOI":"10.1152\/ajprenal.00189.2004","volume":"288","author":"D Sinha","year":"2005","unstructured":"Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC (2005) Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol 288(4):F703\u2013F713. https:\/\/doi.org\/10.1152\/ajprenal.00189.2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"5379_CR174","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.kint.2017.12.017","volume":"93","author":"DWL Wong","year":"2018","unstructured":"Wong DWL, Yiu WH, Chan KW, Li Y, Li B, Lok SWY, Taketo MM, Igarashi P, Chan LYY, Leung JCK, Lai KN, Tang SCW (2018) Activated renal tubular Wnt\/\u03b2-catenin signaling triggers renal inflammation during overload proteinuria. Kidney Int 93(6):1367\u20131383. https:\/\/doi.org\/10.1016\/j.kint.2017.12.017","journal-title":"Kidney Int"},{"issue":"1","key":"5379_CR175","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1681\/ASN.2017040391","volume":"29","author":"Y Feng","year":"2018","unstructured":"Feng Y, Ren J, Gui Y, Wei W, Shu B, Lu Q, Xue X, Sun X, He W, Yang J, Dai C (2018) Wnt\/\u03b2-catenin-promoted macrophage alternative activation contributes to kidney fibrosis. J Am Soc Nephrol 29(1):182\u2013193. https:\/\/doi.org\/10.1681\/ASN.2017040391","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"5379_CR176","doi-asserted-by":"publisher","first-page":"21290","DOI":"10.1074\/jbc.M112.357202","volume":"287","author":"P Zhang","year":"2012","unstructured":"Zhang P, Cai Y, Soofi A, Dressler GR (2012) Activation of Wnt11 by transforming growth factor-\u03b2 drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem 287(25):21290\u201321302. https:\/\/doi.org\/10.1074\/jbc.M112.357202","journal-title":"J Biol Chem"},{"issue":"12","key":"5379_CR177","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1681\/ASN.2016121351","volume":"28","author":"S Nlandu-Khodo","year":"2017","unstructured":"Nlandu-Khodo S, Neelisetty S, Phillips M, Manolopoulou M, Bhave G, May L, Clark PE, Yang H, Fogo AB, Harris RC, Taketo MM, Lee E, Gewin LS (2017) Blocking TGF-\u03b2 and \u03b2-catenin epithelial crosstalk exacerbates CKD. J Am Soc Nephrol 28(12):3490\u20133503. https:\/\/doi.org\/10.1681\/ASN.2016121351","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5379_CR178","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1681\/ASN.2016121362","volume":"29","author":"X Qiao","year":"2018","unstructured":"Qiao X, Rao P, Zhang Y, Liu L, Pang M, Wang H, Hu M, Tian X, Zhang J, Zhao Y, Wang XM, Wang C, Yu H, Guo F, Cao Q, Wang Y, Wang YM, Zhang GY, Lee VW, Alexander SI, Zheng G, Harris DCH (2018) Redirecting TGF-\u03b2 signaling through the \u03b2-catenin\/Foxo complex prevents kidney fibrosis. J Am Soc Nephrol 29(2):557\u2013570. https:\/\/doi.org\/10.1681\/ASN.2016121362","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"5379_CR179","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1681\/ASN.2016070811","volume":"28","author":"Z Li","year":"2017","unstructured":"Li Z, Zhou L, Wang Y, Miao J, Hong X, Hou FF, Liu Y (2017) (Pro)renin receptor is an amplifier of Wnt\/\u03b2-catenin signaling in kidney injury and fibrosis. J Am Soc Nephrol 28(8):2393\u20132408. https:\/\/doi.org\/10.1681\/ASN.2016070811","journal-title":"J Am Soc Nephrol"},{"key":"5379_CR180","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2020.03.024","volume":"301","author":"P Boucher","year":"2020","unstructured":"Boucher P, Matz RL, Terrand J (2020) Atherosclerosis: gone with the Wnt? Atherosclerosis 301:15\u201322. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.03.024","journal-title":"Atherosclerosis"},{"issue":"5816","key":"5379_CR181","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1126\/science.1136370","volume":"315","author":"A Mani","year":"2007","unstructured":"Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315(5816):1278\u20131282. https:\/\/doi.org\/10.1126\/science.1136370","journal-title":"Science"},{"issue":"9","key":"5379_CR182","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/humu.22360","volume":"34","author":"R Singh","year":"2013","unstructured":"Singh R, Smith E, Fathzadeh M, Liu W, Go GW, Subrahmanyan L, Faramarzi S, McKenna W, Mani A (2013) Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum Mutat 34(9):1221\u20131225. https:\/\/doi.org\/10.1002\/humu.22360","journal-title":"Hum Mutat"},{"issue":"5","key":"5379_CR183","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.trsl.2007.12.005","volume":"151","author":"Z Al-Aly","year":"2008","unstructured":"Al-Aly Z (2008) Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res 151(5):233\u2013239. https:\/\/doi.org\/10.1016\/j.trsl.2007.12.005","journal-title":"Transl Res"},{"issue":"2","key":"5379_CR184","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4049\/jimmunol.1000181","volume":"185","author":"J Kim","year":"2010","unstructured":"Kim J, Kim J, Kim DW, Ha Y, Ihm MH, Kim H, Song K, Lee I (2010) Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J Immunol 185(2):1274\u20131282. https:\/\/doi.org\/10.4049\/jimmunol.1000181","journal-title":"J Immunol"},{"issue":"7","key":"5379_CR185","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00109-017-1529-1","volume":"95","author":"A Abraityte","year":"2017","unstructured":"Abraityte A, Vinge LE, Askevold ET, Lekva T, Michelsen AE, Ranheim T, Alfsnes K, Fiane A, Aakhus S, Lunde IG, Dahl CP, Aukrust P, Christensen G, Gullestad L, Yndestad A, Ueland T (2017) Wnt5a is elevated in heart failure and affects cardiac fibroblast function. J Mol Med (Berl) 95(7):767\u2013777. https:\/\/doi.org\/10.1007\/s00109-017-1529-1","journal-title":"J Mol Med (Berl)"},{"key":"5379_CR186","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67932","volume":"10","author":"A Weinstock","year":"2021","unstructured":"Weinstock A, Rahman K, Yaacov O, Nishi H, Menon P, Nikain CA, Garabedian ML, Pena S, Akbar N, Sansbury BE, Heffron SP, Liu J, Marecki G, Fernandez D, Brown EJ, Ruggles KV, Ramsey SA, Giannarelli C, Spite M, Choudhury RP, Loke P, Fisher EA (2021) Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis. Elife 10:e67932. https:\/\/doi.org\/10.7554\/eLife.67932. (Mar 15;)","journal-title":"Elife"},{"issue":"4","key":"5379_CR187","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jjcc.2021.04.010","volume":"78","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wu H, He R, Ye C, Chen H, Wang J, Li Z (2021) Dickkopf-2 knockdown protects against classic macrophage polarization and lipid loading by activation of Wnt\/\u03b2-catenin signaling. J Cardiol 78(4):328\u2013333. https:\/\/doi.org\/10.1016\/j.jjcc.2021.04.010","journal-title":"J Cardiol"},{"issue":"23","key":"5379_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315330","volume":"23","author":"M Acosta-Martinez","year":"2022","unstructured":"Acosta-Martinez M, Cabail MZ (2022) The PI3K\/Akt pathway in meta-inflammation. Int J Mol Sci 23(23):15330. https:\/\/doi.org\/10.3390\/ijms232315330","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5379_CR189","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5379_CR190","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD (2020) The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 20(2):74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"5379_CR191","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P (2024) The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int J Biol Sci 20(8):3113\u20133125. https:\/\/doi.org\/10.7150\/ijbs.89942","journal-title":"Int J Biol Sci"},{"issue":"3","key":"5379_CR192","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","volume":"198","author":"E Vergadi","year":"2017","unstructured":"Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C (2017) Akt signaling pathway in macrophage activation and M1\/M2 polarization. J Immunol 198(3):1006\u20131014. https:\/\/doi.org\/10.4049\/jimmunol.1601515","journal-title":"J Immunol"},{"issue":"19","key":"5379_CR193","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.4161\/cc.21572","volume":"11","author":"TD Troutman","year":"2012","unstructured":"Troutman TD, Bazan JF, Pasare C (2012) Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle 11(19):3559\u20133567. https:\/\/doi.org\/10.4161\/cc.21572","journal-title":"Cell Cycle"},{"key":"5379_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00181","volume":"3","author":"JF Tanti","year":"2013","unstructured":"Tanti JF, Ceppo F, Jager J, Berthou F (2013) Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne) 3:181. https:\/\/doi.org\/10.3389\/fendo.2012.00181","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"5379_CR195","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4049\/jimmunol.2100230","volume":"207","author":"SL Collins","year":"2021","unstructured":"Collins SL, Oh MH, Sun IH, Chan-Li Y, Zhao L, Powell JD, Horton MR (2021) mTORC1 signaling regulates proinflammatory macrophage function and metabolism. J Immunol 207(3):913\u2013922. https:\/\/doi.org\/10.4049\/jimmunol.2100230","journal-title":"J Immunol"},{"issue":"2","key":"5379_CR196","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/15548627.2015.1009787","volume":"11","author":"K Liu","year":"2015","unstructured":"Liu K, Zhao E, Ilyas G, Lalazar G, Lin Y, Haseeb M, Tanaka KE, Czaja MJ (2015) Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 11(2):271\u2013284. https:\/\/doi.org\/10.1080\/15548627.2015.1009787","journal-title":"Autophagy"},{"issue":"1","key":"5379_CR197","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/MCB.06159-11","volume":"32","author":"S Alers","year":"2012","unstructured":"Alers S, L\u00f6ffler AS, Wesselborg S, Stork B (2012) Role of AMPK-mTOR-Ulk1\/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 32(1):2\u201311. https:\/\/doi.org\/10.1128\/MCB.06159-11","journal-title":"Mol Cell Biol"},{"issue":"Apr 21","key":"5379_CR198","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0092-8674(89)90968-9","volume":"57","author":"MJ Birnbaum","year":"1989","unstructured":"Birnbaum MJ (1989) Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57(Apr 21):305\u2013315. https:\/\/doi.org\/10.1016\/0092-8674(89)90968-9","journal-title":"Cell"},{"issue":"10","key":"5379_CR199","doi-asserted-by":"publisher","first-page":"E1205","DOI":"10.1152\/ajpendo.00625.2013","volume":"306","author":"VL Nelson","year":"2014","unstructured":"Nelson VL, Jiang YP, Dickman KG, Ballou LM, Lin RZ (2014) Adipose tissue insulin resistance due to loss of PI3K p110\u03b1 leads to decreased energy expenditure and obesity. Am J Physiol Endocrinol Metab 306(10):E1205\u2013E1216. https:\/\/doi.org\/10.1152\/ajpendo.00625.2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"5379_CR200","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2337\/db15-1128","volume":"65","author":"RP Vazirani","year":"2016","unstructured":"Vazirani RP, Verma A, Sadacca LA, Buckman MS, Picatoste B, Beg M, Torsitano C, Bruno JH, Patel RT, Simonyte K, Camporez JP, Moreira G, Falcone DJ, Accili D, Elemento O, Shulman GI, Kahn BB, McGraw TE (2016) Disruption of adipose Rab10-dependent insulin signaling causes hepatic insulin resistance. Diabetes 65(6):1577\u20131589. https:\/\/doi.org\/10.2337\/db15-1128","journal-title":"Diabetes"},{"issue":"1\u20132","key":"5379_CR201","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","volume":"156","author":"ED Rosen","year":"2014","unstructured":"Rosen ED, Spiegelman BM (2014) What we talk about when we talk about fat. Cell 156(1\u20132):20\u201344. https:\/\/doi.org\/10.1016\/j.cell.2013.12.012","journal-title":"Cell"},{"issue":"4","key":"5379_CR202","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu MS, Patimah I, Khaza\u2019ai H, Rahmat A, Abed Y (2017) Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 13(4):851\u2013863. https:\/\/doi.org\/10.5114\/aoms.2016.58928","journal-title":"Arch Med Sci"},{"key":"5379_CR203","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3389\/fimmu.2015.00637","volume":"6","author":"A Castoldi","year":"2016","unstructured":"Castoldi A, Naffah de Souza C, C\u00e2mara NO, Moraes-Vieira PM (2016) The macrophage switch in obesity development. Front Immunol 6:637. https:\/\/doi.org\/10.3389\/fimmu.2015.00637","journal-title":"Front Immunol"},{"key":"5379_CR204","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32:S157\u2013S163. https:\/\/doi.org\/10.2337\/dc09-S302","journal-title":"Diabetes Care"},{"issue":"5522","key":"5379_CR205","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","volume":"292","author":"H Cho","year":"2001","unstructured":"Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292(5522):1728\u20131731. https:\/\/doi.org\/10.1126\/science.292.5522.1728","journal-title":"Science"},{"issue":"2","key":"5379_CR206","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00125-007-0862-2","volume":"51","author":"IM Jazet","year":"2008","unstructured":"Jazet IM, Schaart G, Gastaldelli A, Ferrannini E, Hesselink MK, Schrauwen P, Romijn JA, Maassen JA, Pijl H, Ouwens DM, Meinders AE (2008) Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 51(2):309\u2013319. https:\/\/doi.org\/10.1007\/s00125-007-0862-2","journal-title":"Diabetologia"},{"issue":"1","key":"5379_CR207","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1017\/S0029665107005277","volume":"66","author":"P Schrauwen","year":"2007","unstructured":"Schrauwen P (2007) High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc 66(1):33\u201341. https:\/\/doi.org\/10.1017\/S0029665107005277","journal-title":"Proc Nutr Soc"},{"key":"5379_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01566","volume":"9","author":"W Mu","year":"2019","unstructured":"Mu W, Cheng XF, Liu Y, Lv QZ, Liu GL, Zhang JG, Li XY (2019) Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues. Front Pharmacol 9:1566. https:\/\/doi.org\/10.3389\/fphar.2018.01566","journal-title":"Front Pharmacol"},{"issue":"3","key":"5379_CR209","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.mol.0000319118.44995.9a","volume":"19","author":"EW Kraegen","year":"2008","unstructured":"Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19(3):235\u2013241. https:\/\/doi.org\/10.1097\/01.mol.0000319118.44995.9a","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"5379_CR210","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrendo.2016.104","volume":"12","author":"MK Hesselink","year":"2016","unstructured":"Hesselink MK, Schrauwen-Hinderling V, Schrauwen P (2016) Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus. Nat Rev Endocrinol 12(11):633\u2013645. https:\/\/doi.org\/10.1038\/nrendo.2016.104","journal-title":"Nat Rev Endocrinol"},{"key":"5379_CR211","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2147\/DDDT.S310882","volume":"15","author":"L Lei","year":"2021","unstructured":"Lei L, Zhao J, Liu XQ, Chen J, Qi XM, Xia LL, Wu YG (2021) Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K\/Akt\/NF-\u03baB signaling pathways. Drug Des Devel Ther 15:3131\u20133150. https:\/\/doi.org\/10.2147\/DDDT.S310882","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5379_CR212","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13020-021-00563-7","volume":"17","author":"Z Ma","year":"2022","unstructured":"Ma Z, Liu Y, Li C, Zhang Y, Lin N (2022) Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K\/AKT\/NF-kB activation. Chin Med 17(1):2. https:\/\/doi.org\/10.1186\/s13020-021-00563-7","journal-title":"Chin Med"},{"key":"5379_CR213","doi-asserted-by":"publisher","first-page":"108610","DOI":"10.1016\/j.intimp.2022.108610","volume":"107","author":"C Gao","year":"2022","unstructured":"Gao C, Fei X, Wang M, Chen Q, Zhao N (2022) Cardamomin protects from diabetes-induced kidney damage through modulating PI3K\/AKT and JAK\/STAT signaling pathways in rats. Int Immunopharmacol 107:108610. https:\/\/doi.org\/10.1016\/j.intimp.2022.108610","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5379_CR214","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1039\/c8fo00131f","volume":"9","author":"HH Arab","year":"2018","unstructured":"Arab HH, Salama SA, Maghrabi IA (2018) Camel milk attenuates methotrexate-induced kidney injury via activation of PI3K\/Akt\/eNOS signaling and intervention with oxidative aberrations. Food Funct 9(5):2661\u20132672. https:\/\/doi.org\/10.1039\/c8fo00131f","journal-title":"Food Funct"},{"issue":"2019","key":"5379_CR215","doi-asserted-by":"publisher","first-page":"1875471","DOI":"10.1155\/2019\/1875471","volume":"18","author":"M Wang","year":"2019","unstructured":"Wang M, Hu R, Wang Y, Liu L, You H, Zhang J, Wu X, Pei T, Wang F, Lu L, Xiao W, Wei L (2019) Atractylenolide III attenuates muscle wasting in chronic kidney disease via the oxidative stress-mediated PI3K\/AKT\/mTOR pathway. Oxid Med Cell Longev 18(2019):1875471. https:\/\/doi.org\/10.1155\/2019\/1875471","journal-title":"Oxid Med Cell Longev"},{"key":"5379_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106959","volume":"88","author":"P Liu","year":"2020","unstructured":"Liu P, Xue Y, Zheng B, Liang Y, Zhang J, Shi J, Chu X, Han X, Chu L (2020) Crocetin attenuates the oxidative stress, inflammation and apoptosisin arsenic trioxide-induced nephrotoxic rats: implication of PI3K\/AKT pathway. Int Immunopharmacol 88:106959. https:\/\/doi.org\/10.1016\/j.intimp.2020.106959","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5379_CR217","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-019-1696-9","volume":"10","author":"D Wang","year":"2019","unstructured":"Wang D, Jin M, Zhao X, Zhao T, Lin W, He Z, Fan M, Jin W, Zhou J, Jin L, Zheng C, Jin H, Zhao Y, Li X, Ying L, Wang Y, Zhu G, Huang Z (2019) FGF1\u0394HBS ameliorates chronic kidney disease via PI3K\/AKT mediated suppression of oxidative stress and inflammation. Cell Death Dis 10(6):464. https:\/\/doi.org\/10.1038\/s41419-019-1696-9","journal-title":"Cell Death Dis"},{"issue":"8","key":"5379_CR218","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/s41401-021-00820-3","volume":"43","author":"D Li","year":"2022","unstructured":"Li D, Guo YY, Cen XF, Qiu HL, Chen S, Zeng XF, Zeng Q, Xu M, Tang QZ (2022) Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-\u03baB pathways. Acta Pharmacol Sin 43(8):1989\u20132002. https:\/\/doi.org\/10.1038\/s41401-021-00820-3","journal-title":"Acta Pharmacol Sin"},{"key":"5379_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152949","volume":"62","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Wang Q, Yang X, Ren Y, Jiao S, Zhu Q, Guo D, Xia K, Wang Y, Li C, Wang W (2019) Qishen granule attenuates cardiac fibrosis by regulating TGF-\u03b2 \/Smad3 and GSK-3\u03b2 pathway. Phytomedicine 62:152949. https:\/\/doi.org\/10.1016\/j.phymed.2019.152949","journal-title":"Phytomedicine"},{"issue":"1","key":"5379_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48970-2","volume":"15","author":"YL Ma","year":"2024","unstructured":"Ma YL, Kong CY, Guo Z, Wang MY, Wang P, Liu FY, Yang D, Yang Z, Tang QZ (2024) Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5\/NR4a1 axis. Nat Commun 15(1):4757. https:\/\/doi.org\/10.1038\/s41467-024-48970-2","journal-title":"Nat Commun"},{"issue":"4","key":"5379_CR221","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/15548627.2020.1741202","volume":"17","author":"S Pi","year":"2021","unstructured":"Pi S, Mao L, Chen J, Shi H, Liu Y, Guo X, Li Y, Zhou L, He H, Yu C, Liu J, Dang Y, Xia Y, He Q, Jin H, Li Y, Hu Y, Miao Y, Yue Z, Hu B (2021) The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy 17(4):980\u20131000. https:\/\/doi.org\/10.1080\/15548627.2020.1741202","journal-title":"Autophagy"},{"issue":"5332","key":"5379_CR222","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr.","year":"1997","unstructured":"Darnell JE Jr. (1997) STATs and gene regulation. Science 277(5332):1630\u20131635. https:\/\/doi.org\/10.1126\/science.277.5332.1630","journal-title":"Science"},{"issue":"1","key":"5379_CR223","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5379_CR224","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234\u2013248. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"5379_CR225","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.5114\/aoms\/158534","volume":"19","author":"MK Tawfik","year":"2023","unstructured":"Tawfik MK, Badran DI, Keshawy MM, Makary S, Abdo M (2023) Alternate-day fat diet and exenatide modulate the brain leptin JAK2\/STAT3\/SOCS3 pathway in a fat diet-induced obesity and insulin resistance mouse model. Arch Med Sci 19(5):1508\u20131519. https:\/\/doi.org\/10.5114\/aoms\/158534","journal-title":"Arch Med Sci"},{"issue":"1","key":"5379_CR226","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31126-5","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Song J, Gao J, Cheng J, Xie H, Zhang L, Wang YH, Gao Z, Wang Y, Wang X, He J, Liu S, Yu Q, Zhang S, Xiong F, Zhou Q, Wang CY (2022) Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR\/STAT3\/IL-6 signaling. Nat Commun 13(1):3489. https:\/\/doi.org\/10.1038\/s41467-022-31126-5","journal-title":"Nat Commun"},{"issue":"1","key":"5379_CR227","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.2010.05799.x","volume":"1212","author":"BF Belgardt","year":"2010","unstructured":"Belgardt BF, Br\u00fcning JC (2010) CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 1212(1):97\u2013113. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05799.x","journal-title":"Ann N Y Acad Sci"},{"issue":"16","key":"5379_CR228","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/febs.13709","volume":"283","author":"EN Gurzov","year":"2016","unstructured":"Gurzov EN, Stanley WJ, Pappas EG, Thomas HE, Gough DJ (2016) The JAK\/STAT pathway in obesity and diabetes. FEBS J 283(16):3002\u20133015. https:\/\/doi.org\/10.1111\/febs.13709","journal-title":"FEBS J"},{"issue":"7","key":"5379_CR229","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/CIRCULATIONAHA.116.026796","volume":"136","author":"H Li","year":"2017","unstructured":"Li H, Cai J, Chen R, Zhao Z, Ying Z, Wang L, Chen J, Hao K, Kinney PL, Chen H, Kan H (2017) Particulate matter exposure and stress hormone levels: a randomized, double-blind. Crossover Trial of Air Purif Circ 136(7):618\u2013627. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026796","journal-title":"Crossover Trial of Air Purif Circ"},{"issue":"6","key":"5379_CR230","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.cell.2014.10.058","volume":"159","author":"SE Simonds","year":"2014","unstructured":"Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, Bassi J, Elmquist JK, Keogh JM, Henning E, Myers MG Jr, Licinio J, Brown RD, Enriori PJ, O\u2019Rahilly S, Sternson SM, Grove KL, Spanswick DC, Farooqi IS, Cowley MA (2014) Leptin mediates the increase in blood pressure associated with obesity. Cell 159(6):1404\u20131416. https:\/\/doi.org\/10.1016\/j.cell.2014.10.058","journal-title":"Cell"},{"issue":"2","key":"5379_CR231","doi-asserted-by":"publisher","first-page":"e23878","DOI":"10.4161\/jkst.23878","volume":"2","author":"CM Wunderlich","year":"2013","unstructured":"Wunderlich CM, H\u00f6velmeyer N, Wunderlich FT (2013) Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT 2(2):e23878. https:\/\/doi.org\/10.4161\/jkst.23878","journal-title":"JAKSTAT"},{"issue":"50","key":"5379_CR232","doi-asserted-by":"publisher","first-page":"21499","DOI":"10.1073\/pnas.1016147107","volume":"107","author":"J Yang","year":"2010","unstructured":"Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, Stark GR (2010) Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci USA 107(50):21499\u201321504. https:\/\/doi.org\/10.1073\/pnas.1016147107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"5379_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08547-0","volume":"7","author":"Z Ma","year":"2017","unstructured":"Ma Z, Yang Y, Di S, Feng X, Liu D, Jiang S, Hu W, Qin Z, Li Y, Lv J, Fan C, Yan X, Li X (2017) Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress. Sci Rep 7(1):8091. https:\/\/doi.org\/10.1038\/s41598-017-08547-0","journal-title":"Sci Rep"},{"issue":"1","key":"5379_CR234","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/dmrr.568","volume":"22","author":"A Sj\u00f6holm","year":"2006","unstructured":"Sj\u00f6holm A, Nystr\u00f6m T (2006) Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 22(1):4\u201310. https:\/\/doi.org\/10.1002\/dmrr.568","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"5379_CR235","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.dsx.2018.11.061","volume":"13","author":"H Elimam","year":"2019","unstructured":"Elimam H, Abdulla AM, Taha IM (2019) Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr 13(1):800\u2013804. https:\/\/doi.org\/10.1016\/j.dsx.2018.11.061","journal-title":"Diabetes Metab Syndr"},{"key":"5379_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00240","volume":"3","author":"YB Tripathi","year":"2012","unstructured":"Tripathi YB, Pandey V (2012) Obesity and endoplasmic reticulum (ER) stresses. Front Immunol 3:240. https:\/\/doi.org\/10.3389\/fimmu.2012.00240","journal-title":"Front Immunol"},{"issue":"12","key":"5379_CR237","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/intimm\/dxab055","volume":"33","author":"A Yoshimura","year":"2021","unstructured":"Yoshimura A, Ito M, Mise-Omata S, Ando M (2021) SOCS: negative regulators of cytokine signaling for immune tolerance. Int Immunol 33(12):711\u2013716. https:\/\/doi.org\/10.1093\/intimm\/dxab055","journal-title":"Int Immunol"},{"issue":"3","key":"5379_CR238","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jcb.24402","volume":"114","author":"MS Akash","year":"2013","unstructured":"Akash MS, Rehman K, Chen S (2013) Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114(3):525\u2013531. https:\/\/doi.org\/10.1002\/jcb.24402","journal-title":"J Cell Biochem"},{"key":"5379_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110691","volume":"200","author":"S Suren Garg","year":"2023","unstructured":"Suren Garg S, Kushwaha K, Dubey R, Gupta J (2023) Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions. Diabetes Res Clin Pract 200:110691. https:\/\/doi.org\/10.1016\/j.diabres.2023.110691","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"5379_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142163","volume":"11","author":"T Speelman","year":"2022","unstructured":"Speelman T, Dale L, Louw A, Verhoog NJD (2022) The association of acute phase proteins in stress and inflammation-induced T2D. Cells 11(14):2163. https:\/\/doi.org\/10.3390\/cells11142163","journal-title":"Cells"},{"issue":"6","key":"5379_CR241","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2337\/db11-0499","volume":"61","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhou B, Zhang F, Wu J, Hu Y, Liu Y, Zhai Q (2012) Amyloid-\u03b2 induces hepatic insulin resistance by activating JAK2\/STAT3\/SOCS-1 signaling pathway. Diabetes 61(6):1434\u20131443. https:\/\/doi.org\/10.2337\/db11-0499","journal-title":"Diabetes"},{"issue":"1","key":"5379_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166901","volume":"1870","author":"Q Meng","year":"2024","unstructured":"Meng Q, Li Y, Xu Y, Wang Y (2024) Acetobacter and Lactobacillus alleviate the symptom of insulin resistance by blocking the JNK-JAK\/STAT pathway in Drosophila melanogaster. Biochimica et Biophysica Acta (BBA) 1870(1):166901. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166901","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"5379_CR243","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","volume":"24","author":"FC Brosius 3rd","year":"2015","unstructured":"Brosius FC 3rd, He JC (2015) Jak inhibition and progressive kidney disease. Curr Opin Nephrol Hypertens 24(1):88\u201395. https:\/\/doi.org\/10.1097\/MNH.0000000000000079","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"5379_CR244","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.kint.2016.10.039","volume":"91","author":"M Fragiadaki","year":"2017","unstructured":"Fragiadaki M, Lannoy M, Themanns M, Maurer B, Leonhard WN, Peters DJ, Moriggl R, Ong AC (2017) STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney Int 91(3):575\u2013586. https:\/\/doi.org\/10.1016\/j.kint.2016.10.039","journal-title":"Kidney Int"},{"issue":"7","key":"5379_CR245","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2215\/CJN.11010919","volume":"15","author":"J Tao","year":"2020","unstructured":"Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA (2020) JAK-STAT activity in peripheral blood cells and kidney tissue in IgA nephropathy. Clin J Am Soc Nephrol 15(7):973\u2013982. https:\/\/doi.org\/10.2215\/CJN.11010919","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5379_CR246","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.kint.2017.03.027","volume":"92","author":"H Zhang","year":"2017","unstructured":"Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG Jr, Werner T, Kretzler M, Brosius FC (2017) Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice. Kidney Int 92(4):909\u2013921. https:\/\/doi.org\/10.1016\/j.kint.2017.03.027","journal-title":"Kidney Int"},{"key":"5379_CR247","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.576988","volume":"8","author":"J Li","year":"2020","unstructured":"Li J, Yang Y, Wei S, Chen L, Xue L, Tian H, Tao S (2020) Bixin protects against kidney interstitial fibrosis through promoting STAT6 degradation. Front Cell Dev Biol 8:576988. https:\/\/doi.org\/10.3389\/fcell.2020.576988","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"5379_CR248","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1681\/ASN.2020040523","volume":"31","author":"M Sellmayr","year":"2020","unstructured":"Sellmayr M, Hernandez Petzsche MR, Ma Q, Kr\u00fcger N, Liapis H, Brink A, Lenz B, Angelotti ML, Gnemmi V, Kuppe C, Kim H, Bindels EMJ, Tajti F, Saez-Rodriguez J, Lech M, Kramann R, Romagnani P, Anders HJ, Steiger S (2020) Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease. J Am Soc Nephrol 31(12):2773\u20132792. https:\/\/doi.org\/10.1681\/ASN.2020040523","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5379_CR249","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.kint.2018.05.022","volume":"94","author":"J Tao","year":"2018","unstructured":"Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA (2018) Jak-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis. Kidney Int 94(4):795\u2013808. https:\/\/doi.org\/10.1016\/j.kint.2018.05.022","journal-title":"Kidney Int"},{"key":"5379_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110122","volume":"118","author":"J Jia","year":"2023","unstructured":"Jia J, Xu LH, Deng C, Zhong X, Xie KH, Han RY, Su HW, Tan RZ, Wang L (2023) Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK\/STAT signaling. Int Immunopharmacol 118:110122. https:\/\/doi.org\/10.1016\/j.intimp.2023.110122","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5379_CR251","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01841-1","volume":"22","author":"SH Lee","year":"2024","unstructured":"Lee SH, Kim KH, Lee SM, Park SJ, Lee S, Cha RH, Lee JW, Kim DK, Kim YS, Ye SK, Yang SH (2024) STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation. Cell Commun Signal 22(1):476. https:\/\/doi.org\/10.1186\/s12964-024-01841-1","journal-title":"Cell Commun Signal"},{"key":"5379_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115587","volume":"213","author":"Q Pang","year":"2023","unstructured":"Pang Q, You L, Meng X, Li Y, Deng T, Li D, Zhu B (2023) Regulation of the JAK\/STAT signaling pathway: the promising targets for cardiovascular disease. Biochem Pharmacol 213:115587. https:\/\/doi.org\/10.1016\/j.bcp.2023.115587","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"5379_CR253","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/mmr.2012.1159","volume":"7","author":"S Zhang","year":"2013","unstructured":"Zhang S, Liu X, Goldstein S, Li Y, Ge J, He B, Fei X, Wang Z, Ruiz G (2013) Role of the JAK\/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-\u03baB expression. Mol Med Rep 7(1):93\u201398. https:\/\/doi.org\/10.3892\/mmr.2012.1159","journal-title":"Mol Med Rep"},{"issue":"6766","key":"5379_CR254","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35003221","volume":"403","author":"G Tellides","year":"2000","unstructured":"Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS (2000) Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403(6766):207\u2013211. https:\/\/doi.org\/10.1038\/35003221","journal-title":"Nature"},{"issue":"7","key":"5379_CR255","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/ATVBAHA.115.305464","volume":"35","author":"MC Boshuizen","year":"2015","unstructured":"Boshuizen MC, de Winther MP (2015) Interferons as essential modulators of atherosclerosis. Arterioscler Thromb Vasc Biol 35(7):1579\u20131588. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305464","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9822","key":"5379_CR256","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","volume":"379","author":"N Sarwar","year":"2012","unstructured":"IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP, Braund PS, Hall AS, Chasman DI, Tybj\u00e6rg-Hansen A, Chambers JC, Benjamin EJ, Franks PW, Clarke R, Wilde AA, Trip MD, Steri M, Witteman JC, Qi L, van der Schoot CE, de Faire U, Erdmann J, Stringham HM, Koenig W, Rader DJ, Melzer D, Reich D, Psaty BM, Kleber ME, Panagiotakos DB, Willeit J, Wennberg P, Woodward M, Adamovic S, Rimm EB, Meade TW, Gillum RF, Shaffer JA, Hofman A, Onat A, Sundstr\u00f6m J, Wassertheil-Smoller S, Mellstr\u00f6m D, Gallacher J, Cushman M, Tracy RP, Kauhanen J, Karlsson M, Salonen JT, Wilhelmsen L, Amouyel P, Cantin B, Best LG, Ben-Shlomo Y, Manson JE, Davey-Smith G, de Bakker PI, O\u2019Donnell CJ, Wilson JF, Wilson AG, Assimes TL, Jansson JO, Ohlsson C, Tivesten \u00c5, Ljunggren \u00d6, Reilly MP, Hamsten A, Ingelsson E, Cambien F, Hung J, Thomas GN, Boehnke M, Schunkert H, Asselbergs FW, Kastelein JJ, Gudnason V, Salomaa V, Harris TB, Kooner JS, Allin KH, Nordestgaard BG, Hopewell JC, Goodall AH, Ridker PM, H\u00f3lm H, Watkins H, Ouwehand WH, Samani NJ, Kaptoge S, Di Angelantonio E, Harari O, Danesh J (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379(9822):1205\u20131213. https:\/\/doi.org\/10.1016\/S0140-6736(11)61931-4","journal-title":"Lancet"},{"issue":"3","key":"5379_CR257","doi-asserted-by":"publisher","first-page":"C771","DOI":"10.1152\/ajpcell.00532.2003","volume":"287","author":"CW Ni","year":"2004","unstructured":"Ni CW, Hsieh HJ, Chao YJ, Wang DL (2004) Interleukin-6-induced JAK2\/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Am J Physiol Cell Physiol 287(3):C771\u2013C780. https:\/\/doi.org\/10.1152\/ajpcell.00532.2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"5379_CR258","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.7150\/ijbs.83432","volume":"19","author":"B Liu","year":"2023","unstructured":"Liu B, Shalamu A, Pei Z, Liu L, Wei Z, Qu Y, Song S, Luo W, Dong Z, Weng X, Ge J (2023) A novel mouse model of heart failure with preserved ejection fraction after chronic kidney disease induced by retinol through JAK\/STAT pathway. Int J Biol Sci 19(12):3661\u20133677. https:\/\/doi.org\/10.7150\/ijbs.83432","journal-title":"Int J Biol Sci"},{"issue":"6","key":"5379_CR259","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00395-013-0392-7","volume":"108","author":"F Tullio","year":"2013","unstructured":"Tullio F, Angotti C, Perrelli MG, Penna C, Pagliaro P (2013) Redox balance and cardioprotection. Basic Res Cardiol 108(6):392. https:\/\/doi.org\/10.1007\/s00395-013-0392-7","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"5379_CR260","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s1050-1738(02)00230-x","volume":"13","author":"R Bolli","year":"2003","unstructured":"Bolli R, Dawn B, Xuan YT (2003) Role of the JAK-STAT pathway in protection against myocardial ischemia\/reperfusion injury. Trends Cardiovasc Med 13(2):72\u201379. https:\/\/doi.org\/10.1016\/s1050-1738(02)00230-x","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"5379_CR261","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","volume":"104","author":"P Krishnamurthy","year":"2009","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104(2):e9-18. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.188243","journal-title":"Circ Res"},{"issue":"4","key":"5379_CR262","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.yjmcc.2011.01.002","volume":"50","author":"R Bolli","year":"2011","unstructured":"Bolli R, Stein AB, Guo Y, Wang OL, Rokosh G, Dawn B, Molkentin JD, Sanganalmath SK, Zhu Y, Xuan YT (2011) A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 50(4):589\u2013597. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.01.002","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"5379_CR263","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4161\/jkst.20115","volume":"1","author":"R Kishore","year":"2012","unstructured":"Kishore R, Verma SK (2012) Roles of STATs signaling in cardiovascular diseases. JAK-STAT 1(2):118\u2013124. https:\/\/doi.org\/10.4161\/jkst.20115","journal-title":"JAK-STAT"},{"issue":"3","key":"5379_CR264","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B (2015) Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol 62(3):720\u2013733. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.039","journal-title":"J Hepatol"},{"issue":"5","key":"5379_CR265","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","volume":"23","author":"B Cariou","year":"2012","unstructured":"Cariou B, Charbonnel B, Staels B (2012) Thiazolidinediones and PPAR\u03b3 agonists: time for a reassessment. Trends Endocrinol Metab 23(5):205\u2013215. https:\/\/doi.org\/10.1016\/j.tem.2012.03.001","journal-title":"Trends Endocrinol Metab"},{"issue":"15","key":"5379_CR266","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1096\/fj.03-0269fje","volume":"17","author":"S Luquet","year":"2003","unstructured":"Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17(15):2299\u20132301. https:\/\/doi.org\/10.1096\/fj.03-0269fje","journal-title":"FASEB J"},{"issue":"10","key":"5379_CR267","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1371\/journal.pbio.0020294","volume":"2","author":"YX Wang","year":"2004","unstructured":"Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2(10):e294. https:\/\/doi.org\/10.1371\/journal.pbio.0020294","journal-title":"PLoS Biol"},{"issue":"3","key":"5379_CR268","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00027.2013","volume":"94","author":"JG Neels","year":"2014","unstructured":"Neels JG, Grimaldi PA (2014) Physiological functions of peroxisome proliferator-activated receptor \u03b2. Physiol Rev 94(3):795\u2013858. https:\/\/doi.org\/10.1152\/physrev.00027.2013","journal-title":"Physiol Rev"},{"issue":"3","key":"5379_CR269","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s1097-2765(00)80467-0","volume":"3","author":"HE Xu","year":"1999","unstructured":"Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3(3):397\u2013403. https:\/\/doi.org\/10.1016\/s1097-2765(00)80467-0","journal-title":"Mol Cell"},{"issue":"9","key":"5379_CR270","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","volume":"94","author":"BM Forman","year":"1997","unstructured":"Forman BM, Chen J, Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94(9):4312\u20134317. https:\/\/doi.org\/10.1073\/pnas.94.9.4312","journal-title":"Proc Natl Acad Sci USA"},{"key":"5379_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2270","volume":"3","author":"Y Hou","year":"2012","unstructured":"Hou Y, Moreau F, Chadee K (2012) PPAR\u03b3 is an E3 ligase that induces the degradation of NF\u03baB\/p65. Nat Commun 3:1300. https:\/\/doi.org\/10.1038\/ncomms2270","journal-title":"Nat Commun"},{"issue":"12","key":"5379_CR272","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369\u20132380. https:\/\/doi.org\/10.1038\/sj.emboj.7600244","journal-title":"EMBO J"},{"issue":"12","key":"5379_CR273","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1111\/j.1742-4658.2009.07039.x","volume":"276","author":"NE Buroker","year":"2009","unstructured":"Buroker NE, Barboza J, Huang JY (2009) The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene. FEBS J 276(12):3247\u20133255. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07039.x","journal-title":"FEBS J"},{"issue":"47","key":"5379_CR274","doi-asserted-by":"publisher","first-page":"36703","DOI":"10.1074\/jbc.M004045200","volume":"275","author":"P Delerive","year":"2000","unstructured":"Delerive P, Gervois P, Fruchart JC, Staels B (2000) Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 275(47):36703\u201336707. https:\/\/doi.org\/10.1074\/jbc.M004045200","journal-title":"J Biol Chem"},{"issue":"5","key":"5379_CR275","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1210\/mend.16.5.0826","volume":"16","author":"P Delerive","year":"2002","unstructured":"Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B (2002) DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol 16(5):1029\u20131039. https:\/\/doi.org\/10.1210\/mend.16.5.0826","journal-title":"Mol Endocrinol"},{"issue":"5","key":"5379_CR276","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.28000","volume":"62","author":"R Scirpo","year":"2015","unstructured":"Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M (2015) Stimulation of nuclear receptor peroxisome proliferator-activated receptor-\u03b3 limits NF-\u03baB-dependent inflammation in mouse cystic fibrosis biliary epithelium. Hepatology 62(5):1551\u20131562. https:\/\/doi.org\/10.1002\/hep.28000","journal-title":"Hepatology"},{"issue":"4","key":"5379_CR277","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.biocel.2007.10.007","volume":"40","author":"JH Yu","year":"2008","unstructured":"Yu JH, Kim KH, Kim H (2008) SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2\/STAT3 signaling in pancreas. Int J Biochem Cell Biol 40(4):677\u2013688. https:\/\/doi.org\/10.1016\/j.biocel.2007.10.007","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"5379_CR278","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/mnfr.201600009","volume":"60","author":"HG Ji","year":"2016","unstructured":"Ji HG, Piao JY, Kim SJ, Kim DH, Lee HN, Na HK, Surh YJ (2016) Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPAR\u03b3. Mol Nutr Food Res 60(6):1448\u20131457. https:\/\/doi.org\/10.1002\/mnfr.201600009","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"5379_CR279","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/BJ20050964","volume":"395","author":"R Grau","year":"2006","unstructured":"Grau R, Punz\u00f3n C, Fresno M, I\u00f1iguez MA (2006) Peroxisome-proliferator-activated receptor \u03b1 agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. Biochem J 395(1):81\u201388. https:\/\/doi.org\/10.1042\/BJ20050964","journal-title":"Biochem J"},{"issue":"5","key":"5379_CR280","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2337\/diabetes.51.5.1507","volume":"51","author":"N Khandoudi","year":"2002","unstructured":"Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A (2002) Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase\/activating protein 1 pathway and protects the heart from ischemia\/reperfusion injury. Diabetes 51(5):1507\u20131514. https:\/\/doi.org\/10.2337\/diabetes.51.5.1507","journal-title":"Diabetes"},{"issue":"12","key":"5379_CR281","first-page":"4627","volume":"9","author":"S Han","year":"2003","unstructured":"Han S, Inoue H, Flowers LC, Sidell N (2003) Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Clin Cancer Res 9(12):4627\u20134635","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5379_CR282","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1124\/mol.109.056010","volume":"76","author":"S Aleshin","year":"2009","unstructured":"Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G (2009) Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta\/delta via mutual control of PPAR expression levels. Mol Pharmacol 76(2):414\u2013424. https:\/\/doi.org\/10.1124\/mol.109.056010","journal-title":"Mol Pharmacol"},{"issue":"2\u20133","key":"5379_CR283","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10555-018-9752-y","volume":"37","author":"D Tong","year":"2018","unstructured":"Tong D, Liu Q, Wang LA, Xie Q, Pang J, Huang Y, Wang L, Liu G, Zhang D, Lan W, Jiang J (2018) The roles of the COX2\/PGE2\/EP axis in therapeutic resistance. Cancer Metastasis Rev 37(2\u20133):355\u2013368. https:\/\/doi.org\/10.1007\/s10555-018-9752-y","journal-title":"Cancer Metastasis Rev"},{"key":"5379_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119869","volume":"284","author":"FBM Sousa","year":"2021","unstructured":"Sousa FBM, Pacheco G, Oliveira AP, Nicolau LAD, Lopes ALF, Ferreira-Fernandes H, Pinto GR, Medeiros JVR (2021) Mechanism of preservation of the intestinal mucosa architecture and NF-\u03baB\/PGE2 reduction by hydrogen sulfide on cholera toxin-induced diarrhea in mice. Life Sci 284:119869. https:\/\/doi.org\/10.1016\/j.lfs.2021.119869","journal-title":"Life Sci"},{"issue":"1","key":"5379_CR285","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cyto.2012.10.007","volume":"61","author":"WS Lim","year":"2013","unstructured":"Lim WS, Ng DL, Kor SB, Wong HK, Tengku-Muhammad TS, Choo QC, Chew CH (2013) Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPAR\u03b1) in human hepatocarcinoma HepG2 cells by activation of NF-\u03baB pathway. Cytokine 61(1):266\u2013274. https:\/\/doi.org\/10.1016\/j.cyto.2012.10.007","journal-title":"Cytokine"},{"issue":"7","key":"5379_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104890","volume":"299","author":"K Saito","year":"2023","unstructured":"Saito K, Sekiya M, Kainoh K, Yoshino R, Hayashi A, Han SI, Araki M, Ohno H, Takeuchi Y, Tsuyuzaki T, Yamazaki D, Wanpei C, Hada L, Watanabe S, Paramita Adi Putri PI, Murayama Y, Sugano Y, Osaki Y, Iwasaki H, Yahagi N, Suzuki H, Miyamoto T, Matsuzaka T, Shimano H (2023) Obesity-induced metabolic imbalance allosterically modulates CtBP2 to inhibit PPAR-alpha transcriptional activity. J Biol Chem 299(7):104890. https:\/\/doi.org\/10.1016\/j.jbc.2023.104890","journal-title":"J Biol Chem"},{"issue":"8","key":"5379_CR287","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","volume":"56","author":"P Sivasami","year":"2023","unstructured":"Sivasami P, Elkins C, Diaz-Saldana PP, Goss K, Peng A, Hamersky M 4th, Bae J, Xu M, Pollack BP, Horwitz EM, Scharer CD, Seldin L, Li C (2023) Obesity-induced dysregulation of skin-resident PPAR\u03b3+ Treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity 56(8):1844-1861.e6. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.021","journal-title":"Immunity"},{"issue":"3","key":"5379_CR288","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c190029.PMID:32940941;PMCID:PMC8074531","volume":"10","author":"KE Merz","year":"2020","unstructured":"Merz KE, Thurmond DC (2020) Role of skeletal muscle in insulin resistance and glucose uptake. Compr Physiol 10(3):785\u2013809. https:\/\/doi.org\/10.1002\/cphy.c190029.PMID:32940941;PMCID:PMC8074531","journal-title":"Compr Physiol"},{"issue":"8","key":"5379_CR289","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/sj.bjp.0706002","volume":"143","author":"NK Verma","year":"2004","unstructured":"Verma NK, Singh J, Dey CS (2004) PPAR-gamma expression modulates insulin sensitivity in C2C12 skeletal muscle cells. Br J Pharmacol 143(8):1006\u20131013. https:\/\/doi.org\/10.1038\/sj.bjp.0706002","journal-title":"Br J Pharmacol"},{"issue":"10","key":"5379_CR290","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s00125-014-3331-8","volume":"57","author":"L Salvad\u00f3","year":"2014","unstructured":"Salvad\u00f3 L, Barroso E, G\u00f3mez-Foix AM, Palomer X, Michalik L, Wahli W, V\u00e1zquez-Carrera M (2014) PPAR\u03b2\/\u03b4 prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 57(10):2126\u20132135. https:\/\/doi.org\/10.1007\/s00125-014-3331-8","journal-title":"Diabetologia"},{"issue":"4","key":"5379_CR291","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2020.08.016","volume":"32","author":"JA Hall","year":"2020","unstructured":"Hall JA, Ramachandran D, Roh HC, DiSpirito JR, Belchior T, Zushin PH, Palmer C, Hong S, Mina AI, Liu B, Deng Z, Aryal P, Jacobs C, Tenen D, Brown CW, Charles JF, Shulman GI, Kahn BB, Tsai LTY, Rosen ED, Spiegelman BM, Banks AS (2020) Obesity-linked PPAR\u03b3 S273 phosphorylation promotes insulin resistance through growth differentiation factor 3. Cell Metab 32(4):665-675.e6. https:\/\/doi.org\/10.1016\/j.cmet.2020.08.016","journal-title":"Cell Metab"},{"issue":"4","key":"5379_CR292","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040632","volume":"13","author":"MF Terra","year":"2023","unstructured":"Terra MF, Garc\u00eda-Ar\u00e9valo M, Avelino TM, Degaki KY, de Carvalho M, Torres FR, Saito A, Figueira ACM (2023) Obesity-linked PPAR\u03b3 Ser273 phosphorylation promotes beneficial effects on the liver, despite reduced insulin sensitivity in mice. Biomolecules 13(4):632. https:\/\/doi.org\/10.3390\/biom13040632","journal-title":"Biomolecules"},{"issue":"3","key":"5379_CR293","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101030","volume":"297","author":"RL Frkic","year":"2021","unstructured":"Frkic RL, Richter K, Bruning JB (2021) The therapeutic potential of inhibiting PPAR\u03b3 phosphorylation to treat type 2 diabetes. J Biol Chem 297(3):101030. https:\/\/doi.org\/10.1016\/j.jbc.2021.101030","journal-title":"J Biol Chem"},{"issue":"4","key":"5379_CR294","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2337\/dc06-1332","volume":"30","author":"R De Caterina","year":"2007","unstructured":"De Caterina R, Madonna R, Bertolotto A, Schmidt EB (2007) n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 30(4):1012\u20131026. https:\/\/doi.org\/10.2337\/dc06-1332","journal-title":"Diabetes Care"},{"issue":"3","key":"5379_CR295","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1160\/TH10-09-0574","volume":"106","author":"R Madonna","year":"2011","unstructured":"Madonna R, Salerni S, Schiavone D, Glatz JF, Geng YJ, De Caterina R (2011) Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR \u03b1\/\u03b3 activity in microvascular endothelial cells. Thromb Haemost 106(3):500\u2013510. https:\/\/doi.org\/10.1160\/TH10-09-0574","journal-title":"Thromb Haemost"},{"issue":"8","key":"5379_CR296","doi-asserted-by":"publisher","first-page":"14395","DOI":"10.1038\/ncomms14395","volume":"16","author":"S Hajarnis","year":"2017","unstructured":"Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R, Li J, Kaimal V, Lockton S, Davis S, Flaten A, Johnson JA, Holland WL, Kusminski CM, Scherer PE, Harris PC, Trudel M, Wallace DP, Igarashi P, Lee EC, Androsavich JR, Patel V (2017) microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nat Commun 16(8):14395. https:\/\/doi.org\/10.1038\/ncomms14395","journal-title":"Nat Commun"},{"issue":"1","key":"5379_CR297","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","volume":"314","author":"R Lakhia","year":"2018","unstructured":"Lakhia R, Yheskel M, Flaten A, Quittner-Strom EB, Holland WL, Patel V (2018) PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice. Am J Physiol Renal Physiol 314(1):F122\u2013F131. https:\/\/doi.org\/10.1152\/ajprenal.00352.2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"5379_CR298","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12263-012-0295-5","volume":"7","author":"C Tovar-Palacio","year":"2012","unstructured":"Tovar-Palacio C, Torres N, Diaz-Villase\u00f1or A, Tovar AR (2012) The role of nuclear receptors in the kidney in obesity and metabolic syndrome. Genes Nutr 7(4):483\u2013498. https:\/\/doi.org\/10.1007\/s12263-012-0295-5","journal-title":"Genes Nutr"},{"issue":"4","key":"5379_CR299","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung KW, Lee EK, Lee MK, Oh GT, Yu BP, Chung HY (2018) Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol 29(4):1223\u20131237. https:\/\/doi.org\/10.1681\/ASN.2017070802","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"5379_CR300","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/nm.2048","volume":"15","author":"L Mukundan","year":"2009","unstructured":"Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, Nguyen KD, Steinman L, Michie SA, Chawla A (2009) PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 15(11):1266\u20131272. https:\/\/doi.org\/10.1038\/nm.2048","journal-title":"Nat Med"},{"issue":"3","key":"5379_CR301","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00004872-200103000-00019","volume":"19","author":"K Yoshida","year":"2001","unstructured":"Yoshida K, Kohzuki M, Xu HL, Wu XM, Kamimoto M, Sato T (2001) Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure. J Hypertens 19(3):503\u2013510. https:\/\/doi.org\/10.1097\/00004872-200103000-00019","journal-title":"J Hypertens"},{"issue":"1","key":"5379_CR302","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/labinvest.2008.104","volume":"89","author":"T Kawai","year":"2009","unstructured":"Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N (2009) PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 89(1):47\u201358. https:\/\/doi.org\/10.1038\/labinvest.2008.104","journal-title":"Lab Invest"},{"issue":"40","key":"5379_CR303","doi-asserted-by":"publisher","first-page":"64690","DOI":"10.18632\/oncotarget.11811","volume":"7","author":"M Zhao","year":"2016","unstructured":"Zhao M, Chen Y, Ding G, Xu Y, Bai M, Zhang Y, Jia Z, Huang S, Zhang A (2016) Renal tubular epithelium-targeted peroxisome proliferator-activated receptor-\u03b3 maintains the epithelial phenotype and antagonizes renal fibrogenesis. Oncotarget 7(40):64690\u201364701. https:\/\/doi.org\/10.18632\/oncotarget.11811","journal-title":"Oncotarget"},{"issue":"1","key":"5379_CR304","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/HYPERTENSIONAHA.117.10799","volume":"72","author":"TM De Silva","year":"2018","unstructured":"De Silva TM, Li Y, Kinzenbaw DA, Sigmund CD, Faraci FM (2018) Endothelial PPAR\u03b3 (Peroxisome Proliferator-Activated Receptor-\u03b3) is essential for preventing endothelial dysfunction with aging. Hypertension 72(1):227\u2013234. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10799","journal-title":"Hypertension"},{"issue":"5","key":"5379_CR305","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.celrep.2019.01.013","volume":"26","author":"CG Li","year":"2019","unstructured":"Li CG, Mahon C, Sweeney NM, Verschueren E, Kantamani V, Li D, Hennigs JK, Marciano DP, Diebold I, Abu-Halawa O, Elliott M, Sa S, Guo F, Wang L, Cao A, Guignabert C, Sollier J, Nickel NP, Kaschwich M, Cimprich KA, Rabinovitch M (2019) PPAR\u03b3 interaction with UBR5\/ATMIN promotes DNA repair to maintain endothelial homeostasis. Cell Rep 26(5):1333-1343.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.013","journal-title":"Cell Rep"},{"issue":"6","key":"5379_CR306","doi-asserted-by":"publisher","first-page":"30053","DOI":"10.1038\/srep30053","volume":"17","author":"J Yu","year":"2016","unstructured":"Yu J, Qiu Y, Yang J, Bian S, Chen G, Deng M, Kang H, Huang L (2016) DNMT1-PPAR\u03b3 pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice. Sci Rep 17(6):30053. https:\/\/doi.org\/10.1038\/srep30053","journal-title":"Sci Rep"},{"issue":"3","key":"5379_CR307","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacbts.2016.11.009","volume":"2","author":"AR Wende","year":"2017","unstructured":"Wende AR, Brahma MK, McGinnis GR, Young ME (2017) Metabolic origins of heart failure. JACC Basic Transl Sci 2(3):297\u2013310. https:\/\/doi.org\/10.1016\/j.jacbts.2016.11.009","journal-title":"JACC Basic Transl Sci"},{"issue":"12","key":"5379_CR308","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1172\/JCI9056","volume":"105","author":"PM Barger","year":"2000","unstructured":"Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP (2000) Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105(12):1723\u20131730. https:\/\/doi.org\/10.1172\/JCI9056","journal-title":"J Clin Invest"},{"issue":"8","key":"5379_CR309","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1096\/fj.201500094R","volume":"30","author":"MA Cole","year":"2016","unstructured":"Cole MA, Abd Jamil AH, Heather LC, Murray AJ, Sutton ER, Slingo M, Sebag-Montefiore L, Tan SC, Aksentijevi\u0107 D, Gildea OS, Stuckey DJ, Yeoh KK, Carr CA, Evans RD, Aasum E, Schofield CJ, Ratcliffe PJ, Neubauer S, Robbins PA, Clarke K (2016) On the pivotal role of PPAR\u03b1 in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury. FASEB J 30(8):2684\u20132697. https:\/\/doi.org\/10.1096\/fj.201500094R","journal-title":"FASEB J"},{"issue":"3","key":"5379_CR310","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2013.08.009","volume":"18","author":"H el Azzouzi","year":"2013","unstructured":"el Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K, McClellan EA, Poels E, Sluimer JC, van den Hoogenhof MM, Armand AS, Yin X, Langley S, Bourajjaj M, Olieslagers S, Krishnan J, Vooijs M, Kurihara H, Stubbs A, Pinto YM, Krek W, Mayr M, da Costa Martins PA, Schrauwen P, De Windt LJ (2013) The hypoxia-inducible microRNA cluster miR-199a\u223c214 targets myocardial PPAR\u03b4 and impairs mitochondrial fatty acid oxidation. Cell Metab 18(3):341\u2013354. https:\/\/doi.org\/10.1016\/j.cmet.2013.08.009","journal-title":"Cell Metab"},{"issue":"24","key":"5379_CR311","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/eurheartj\/ehv120","volume":"36","author":"S Dass","year":"2015","unstructured":"Dass S, Cochlin LE, Suttie JJ, Holloway CJ, Rider OJ, Carden L, Tyler DJ, Karamitsos TD, Clarke K, Neubauer S, Watkins H (2015) Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction. Eur Heart J 36(24):1547\u20131554. https:\/\/doi.org\/10.1093\/eurheartj\/ehv120","journal-title":"Eur Heart J"},{"issue":"16","key":"5379_CR312","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139(16):e840\u2013e878. https:\/\/doi.org\/10.1161\/CIR.0000000000000664","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"5379_CR313","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.hyp.35.1.193","volume":"35","author":"DN Muller","year":"2000","unstructured":"Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC (2000) NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35(1 Pt 2):193\u2013201. https:\/\/doi.org\/10.1161\/01.hyp.35.1.193","journal-title":"Hypertension"},{"issue":"1","key":"5379_CR314","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.intimp.2012.02.014","volume":"13","author":"Y Cao","year":"2012","unstructured":"Cao Y, Jiao Y, Wang L, Huang Y, Postlethwaite A, Stuart J, Kang A, Williams RW, Gu W (2012) Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts\u2013from the point of view of mouse genomics. Int Immunopharmacol 13(1):28\u201336. https:\/\/doi.org\/10.1016\/j.intimp.2012.02.014","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5379_CR315","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10067-014-2601-7","volume":"34","author":"A Vitale","year":"2015","unstructured":"Vitale A, Cantarini L, Rigante D, Bardelli M, Galeazzi M (2015) Anakinra treatment in patients with gout and type 2 diabetes. Clin Rheumatol 34(5):981\u2013984. https:\/\/doi.org\/10.1007\/s10067-014-2601-7","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5379_CR316","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2015.06.003","volume":"160","author":"EJ van Asseldonk","year":"2015","unstructured":"van Asseldonk EJ, van Poppel PC, Ballak DB, Stienstra R, Netea MG, Tack CJ (2015) One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus. Clin Immunol 160(2):155\u2013162. https:\/\/doi.org\/10.1016\/j.clim.2015.06.003","journal-title":"Clin Immunol"},{"issue":"2","key":"5379_CR317","doi-asserted-by":"publisher","first-page":"403","DOI":"10.55563\/clinexprheumatol\/phsqg7","volume":"39","author":"P Ruscitti","year":"2021","unstructured":"Ruscitti P, Berardicurti O, Cipriani P, Giacomelli R, TRACK study group (2021) Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial. Clin Exp Rheumatol 39(2):403\u2013406. https:\/\/doi.org\/10.55563\/clinexprheumatol\/phsqg7","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"5379_CR318","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.39995","volume":"69","author":"I Ben-Zvi","year":"2017","unstructured":"Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A (2017) Anakinra for Colchicine-Resistant familial mediterranean fever: a randomized, double-blind. Placebo-Control Trial Arthritis Rheumatol 69(4):854\u2013862. https:\/\/doi.org\/10.1002\/art.39995","journal-title":"Placebo-Control Trial Arthritis Rheumatol"},{"issue":"3","key":"5379_CR319","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1681\/ASN.2010070760","volume":"22","author":"AM Hung","year":"2011","unstructured":"Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA (2011) IL-1\u03b2 receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol 22(3):437\u2013442. https:\/\/doi.org\/10.1681\/ASN.2010070760","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5379_CR320","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jbspin.2018.03.015","volume":"85","author":"C Loustau","year":"2018","unstructured":"Loustau C, Rosine N, Forien M, Ottaviani S, Juge PA, Liot\u00e9 F, Bardin T, Richette P, Dieud\u00e9 P, Richez C, Bannwarth B, Schaeverbeke T, Ea HK, Truchetet ME (2018) Effectiveness and safety of anakinra in gout patients with stage 4\u20135 chronic kidney disease or kidney transplantation: a multicentre, retrospective study. Joint Bone Spine 85(6):755\u2013760. https:\/\/doi.org\/10.1016\/j.jbspin.2018.03.015","journal-title":"Joint Bone Spine"},{"issue":"6","key":"5379_CR321","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/FJC.0000000000000378","volume":"67","author":"BW Van Tassell","year":"2016","unstructured":"Van Tassell BW, Abouzaki NA, Oddi Erdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A (2016) Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded. Placebo-Controlled Pilot Study J Cardiovasc Pharmacol 67(6):544\u2013551. https:\/\/doi.org\/10.1097\/FJC.0000000000000378","journal-title":"Placebo-Controlled Pilot Study J Cardiovasc Pharmacol"},{"issue":"3","key":"5379_CR322","doi-asserted-by":"publisher","first-page":"e33438","DOI":"10.1371\/journal.pone.0033438","volume":"7","author":"BW Van Tassell","year":"2012","unstructured":"Van Tassell BW, Arena RA, Toldo S, Mezzaroma E, Azam T, Seropian IM, Shah K, Canada J, Voelkel NF, Dinarello CA, Abbate A (2012) Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS ONE 7(3):e33438. https:\/\/doi.org\/10.1371\/journal.pone.0033438","journal-title":"PLoS ONE"},{"issue":"6","key":"5379_CR323","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1759720X13502629","volume":"5","author":"JB Kuemmerle-Deschner","year":"2013","unstructured":"Kuemmerle-Deschner JB, Haug I (2013) Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians. Ther Adv Musculoskelet Dis 5(6):315\u2013329. https:\/\/doi.org\/10.1177\/1759720X13502629","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"23","key":"5379_CR324","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","volume":"126","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, Thuren T, CANTOS Pilot Investigative Group (2012) Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 126(23):2739\u20132748. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.122556","journal-title":"Circulation"},{"issue":"53","key":"5379_CR325","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.eclinm.2022.101649","volume":"17","author":"M Hepprich","year":"2022","unstructured":"Hepprich M, Mudry JM, Gregoriano C, Jornayvaz FR, Carballo S, Wojtusciszyn A, Bart PA, Chiche JD, Fischli S, Baumgartner T, Cavelti-Weder C, Braun DL, G\u00fcnthard HF, Beuschlein F, Conen A, West E, Isenring E, Zechmann S, Bucklar G, Aubry Y, Dey L, M\u00fcller B, Hunziker P, Sch\u00fctz P, Cattaneo M, Donath MY (2022) Canakinumab in patients with COVID-19 and type 2 diabetes\u2014a multicentre, randomised, double-blind, placebo-controlled trial. EClinicalMedicine 17(53):101649. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101649","journal-title":"EClinicalMedicine"},{"issue":"21","key":"5379_CR326","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","volume":"71","author":"PM Ridker","year":"2018","unstructured":"Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, Lefkowitz M, Thuren T, Cornel JH (2018) Inhibition of Interleukin-1\u03b2 by Canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol 71(21):2405\u20132414. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.490","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"5379_CR327","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"issue":"10","key":"5379_CR328","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM (2019) Anti-inflammatory therapy with Canakinumab for the prevention of hospitalization for heart failure. Circulation 139(10):1289\u20131299. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038010","journal-title":"Circulation"},{"issue":"4","key":"5379_CR329","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/pedi.12634","volume":"19","author":"PC White","year":"2018","unstructured":"White PC, Adhikari S, Grishman EK, Sumpter KM (2018) A phase I study of anti-inflammatory therapy with rilonacept in adolescents and adults with type 1 diabetes mellitus. Pediatr Diabetes 19(4):788\u2013793. https:\/\/doi.org\/10.1111\/pedi.12634","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"5379_CR330","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2337\/db15-0492","volume":"65","author":"RG Gill","year":"2016","unstructured":"Gill RG, Pagni PP, Kupfer T, Wasserfall CH, Deng S, Posgai A, Manenkova Y, Bel Hani A, Straub L, Bernstein P, Atkinson MA, Herold KC, von Herrath M, Staeva T, Ehlers MR, Nepom GT (2016) A preclinical consortium approach for assessing the efficacy of combined Anti-CD3 Plus IL-1 blockade in reversing new-onset autoimmune diabetes in NOD mice. Diabetes 65(5):1310\u20131316. https:\/\/doi.org\/10.2337\/db15-0492","journal-title":"Diabetes"},{"issue":"7","key":"5379_CR331","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/0091270009351882","volume":"50","author":"A Radin","year":"2010","unstructured":"Radin A, Marbury T, Osgood G, Belomestnov P (2010) Safety and pharmacokinetics of subcutaneously administered rilonacept in patients with well-controlled end-stage renal disease (ESRD). J Clin Pharmacol 50(7):835\u2013841. https:\/\/doi.org\/10.1177\/0091270009351882","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"5379_CR332","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5414\/CN109122","volume":"88","author":"KL Nowak","year":"2017","unstructured":"Nowak KL, Hung A, Ikizler TA, Farmer-Bailey H, Salas-Cruz N, Sarkar S, Hoofnagle A, You Z, Chonchol M (2017) Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function. Clin Nephrol 88(9):132\u2013143. https:\/\/doi.org\/10.5414\/CN109122","journal-title":"Clin Nephrol"},{"issue":"8","key":"5379_CR333","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","volume":"157","author":"PJ Hashkes","year":"2012","unstructured":"Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157(8):533\u2013541. https:\/\/doi.org\/10.7326\/0003-4819-157-8-201210160-00003","journal-title":"Ann Intern Med"},{"issue":"6","key":"5379_CR334","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/heartjnl-2020-317928","volume":"107","author":"AL Klein","year":"2020","unstructured":"Klein AL, Lin D, Cremer PC, Nasir S, Luis SA, Abbate A, Ertel A, LeWinter M, Beutler A, Fang F, Paolini JF (2020) Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial. Heart 107(6):488\u2013496. https:\/\/doi.org\/10.1136\/heartjnl-2020-317928","journal-title":"Heart"},{"issue":"1","key":"5379_CR335","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","volume":"384","author":"AL Klein","year":"2021","unstructured":"Klein AL, Imazio M, Cremer P, Brucato A, Abbate A, Fang F, Insalaco A, LeWinter M, Lewis BS, Lin D, Luis SA, Nicholls SJ, Pano A, Wheeler A, Paolini JF, RHAPSODY Investigators (2021) Phase 3 trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med 384(1):31\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2027892","journal-title":"N Engl J Med"},{"issue":"4","key":"5379_CR336","first-page":"851","volume":"53","author":"K Sato","year":"1993","unstructured":"Sato K, Tsuchiya M, Saldanha J, Koishihara Y, Ohsugi Y, Kishimoto T, Bendig MM (1993) Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res 53(4):851\u2013856","journal-title":"Cancer Res"},{"issue":"9617","key":"5379_CR337","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 371(9617):998\u20131006. https:\/\/doi.org\/10.1016\/S0140-6736(08)60454-7","journal-title":"Lancet"},{"issue":"25","key":"5379_CR338","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A, PRINTO, PRCSG (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 367(25):2385\u20132395. https:\/\/doi.org\/10.1056\/NEJMoa1112802","journal-title":"N Engl J Med"},{"key":"5379_CR339","doi-asserted-by":"publisher","first-page":"155641","DOI":"10.1016\/j.metabol.2023.155641","volume":"146","author":"W Chen","year":"2023","unstructured":"Chen W, Cui W, Wu J, Zheng W, Sun X, Zhang J, Shang H, Yuan Y, Li X, Wang J, Hu X, Chen L, Zeng F, Xiao RP, Zhang X (2023) Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion. Metabolism 146:155641. https:\/\/doi.org\/10.1016\/j.metabol.2023.155641","journal-title":"Metabolism"},{"issue":"4","key":"5379_CR340","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/art.42405","volume":"75","author":"NJ Patel","year":"2023","unstructured":"Patel NJ, Tozzo V, Higgins JM, Stone JH (2023) The effects of daily prednisone and Tocilizumab on Hemoglobin A1c during the treatment of giant cell arteritis. Arthritis Rheumatol 75(4):586\u2013594. https:\/\/doi.org\/10.1002\/art.42405","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5379_CR341","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10787-019-00628-y","volume":"28","author":"YF Ibrahim","year":"2020","unstructured":"Ibrahim YF, Moussa RA, Bayoumi AMA, Ahmed AF (2020) Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-\u03baB\/JNK: a possible role of P-glycoprotein. Inflammopharmacology 28(1):215\u2013230. https:\/\/doi.org\/10.1007\/s10787-019-00628-y","journal-title":"Inflammopharmacology"},{"key":"5379_CR342","doi-asserted-by":"publisher","first-page":"118487","DOI":"10.1016\/j.lfs.2020.118487","volume":"261","author":"L Yang","year":"2020","unstructured":"Yang L, Guo J, Yu N, Liu Y, Song H, Niu J, Gu Y (2020) Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model. Life Sci 261:118487. https:\/\/doi.org\/10.1016\/j.lfs.2020.118487","journal-title":"Life Sci"},{"issue":"4","key":"5379_CR343","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s40620-023-01845-z","volume":"37","author":"C Seneschall","year":"2024","unstructured":"Seneschall C, Law S, Roufosse C, Woodham S, Kousios A (2024) Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report. J Nephrol 37(4):1147\u20131152. https:\/\/doi.org\/10.1007\/s40620-023-01845-z","journal-title":"J Nephrol"},{"issue":"11","key":"5379_CR344","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.cjca.2020.01.003","volume":"36","author":"MJ Hsieh","year":"2020","unstructured":"Hsieh MJ, Lee CH, Tsai ML, Kao CF, Lan WC, Huang YT, Tseng WY, Wen MS, Chang SH (2020) Biologic agents reduce cardiovascular events in Rheumatoid Arthritis not responsive to tumour necrosis factor inhibitors: a national cohort study. Can J Cardiol 36(11):1739\u20131746. https:\/\/doi.org\/10.1016\/j.cjca.2020.01.003","journal-title":"Can J Cardiol"},{"issue":"10","key":"5379_CR345","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3899\/jrheum.131540","volume":"41","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M (2014) Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 41(10):1916\u20131921. https:\/\/doi.org\/10.3899\/jrheum.131540","journal-title":"J Rheumatol"},{"issue":"5","key":"5379_CR346","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/03009742.2017.1418424","volume":"47","author":"I Yokoe","year":"2018","unstructured":"Yokoe I, Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Kitamura N, Takei M (2018) Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms. Scand J Rheumatol 47(5):364\u2013370. https:\/\/doi.org\/10.1080\/03009742.2017.1418424","journal-title":"Scand J Rheumatol"},{"issue":"15","key":"5379_CR347","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","volume":"77","author":"K Broch","year":"2021","unstructured":"Broch K, Anstensrud AK, Woxholt S, Sharma K, T\u00f8llefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Dam\u00e5s JK, Berg ES, Bj\u00f8rkelund E, Bendz C, Hopp E, Kleveland O, Stens\u00e6th KH, Opdahl A, Kl\u00f8w NE, Seljeflot I, Andersen G\u00d8, Wiseth R, Aukrust P, Gullestad L (2021) Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 77(15):1845\u20131855. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.049","journal-title":"J Am Coll Cardiol"},{"key":"5379_CR348","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012\u2013. Sarilumab (2021)"},{"issue":"1","key":"5379_CR349","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13075-020-02229-5","volume":"22","author":"MC Genovese","year":"2020","unstructured":"Genovese MC, Burmester GR, Hagino O, Thangavelu K, Iglesias-Rodriguez M, John GS, Gonz\u00e1lez-Gay MA, Mandrup-Poulsen T, Fleischmann R (2020) Interleukin-6 receptor blockade or TNF\u03b1 inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials. Arthritis Res Ther 22(1):206. https:\/\/doi.org\/10.1186\/s13075-020-02229-5","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5379_CR350","doi-asserted-by":"publisher","first-page":"e13391","DOI":"10.7759\/cureus.13391","volume":"13","author":"M Arias","year":"2021","unstructured":"Arias M, Heydari-Kamjani M, Kesselman MM (2021) Giant cell arteritis and cardiac comorbidity. Cureus 13(2):e13391. https:\/\/doi.org\/10.7759\/cureus.13391","journal-title":"Cureus"},{"issue":"1","key":"5379_CR351","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13075-023-03177-6","volume":"25","author":"WA Schmidt","year":"2023","unstructured":"Schmidt WA, Dasgupta B, Sloane J, Giannelou A, Xu Y, Unizony SH, Mackie SL, Gonzalez-Gay MA, Spiera R, Warrington KJ, Villiger PM, Nivens MC, Akinlade B, Lin Y, Buttgereit F, Stone JH (2023) A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis. Arthritis Res Ther 25(1):199. https:\/\/doi.org\/10.1186\/s13075-023-03177-6","journal-title":"Arthritis Res Ther"},{"issue":"10289","key":"5379_CR352","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","volume":"397","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Devalaraja M, Baeres FMM, Engelmann MDM, Hovingh GK, Ivkovic M, Lo L, Kling D, Pergola P, Raj D, Libby P, Davidson M, RESCUE Investigators (2021) IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 397(10289):2060\u20132069. https:\/\/doi.org\/10.1016\/S0140-6736(21)00520-1","journal-title":"Lancet"},{"issue":"4","key":"5379_CR353","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","volume":"82","author":"Y Wada","year":"2023","unstructured":"Wada Y, Jensen C, Meyer ASP, Zonoozi AAM, Honda H (2023) Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): a randomized, double-blind, placebo-controlled, phase 2 trial. J Cardiol 82(4):279\u2013285. https:\/\/doi.org\/10.1016\/j.jjcc.2023.05.006","journal-title":"J Cardiol"},{"issue":"11","key":"5379_CR354","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","volume":"117","author":"PM Ridker","year":"2021","unstructured":"Ridker PM (2021) From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? Cardiovasc Res 117(11):e138\u2013e140. https:\/\/doi.org\/10.1093\/cvr\/cvab231","journal-title":"Cardiovasc Res"},{"issue":"1","key":"5379_CR355","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, Nanchahal J, Taylor P, Feldmann M (2015) Anti-TNF therapy: past, present and future. Int Immunol 27(1):55\u201362. https:\/\/doi.org\/10.1093\/intimm\/dxu102","journal-title":"Int Immunol"},{"issue":"2","key":"5379_CR356","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117(2):244\u2013279. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.10.001","journal-title":"Pharmacol Ther"},{"issue":"13","key":"5379_CR357","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/BTT.S207246","volume":"30","author":"R Melsheimer","year":"2019","unstructured":"Melsheimer R, Geldhof A, Apaolaza I, Schaible T (2019) Remicade\u00ae (infliximab): 20 years of contributions to science and medicine. Biologics 30(13):139\u2013178. https:\/\/doi.org\/10.2147\/BTT.S207246","journal-title":"Biologics"},{"issue":"9","key":"5379_CR358","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2362.2004.01390.x","volume":"34","author":"B Yazdani-Biuki","year":"2004","unstructured":"Yazdani-Biuki B, Stelzl H, Brezinschek HP, Hermann J, Mueller T, Krippl P, Graninger W, Wascher TC (2004) Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab. Eur J Clin Invest 34(9):641\u2013642. https:\/\/doi.org\/10.1111\/j.1365-2362.2004.01390.x","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"5379_CR359","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/ard.2004.026534","volume":"64","author":"DN Kiortsis","year":"2005","unstructured":"Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA (2005) Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64(5):765\u2013766. https:\/\/doi.org\/10.1136\/ard.2004.026534","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5379_CR360","first-page":"355","volume":"35","author":"B Seriolo","year":"2008","unstructured":"Seriolo B, Ferrone C, Cutolo M (2008) Longterm anti-tumor necrosis factor-alpha treatment in patients with refractory rheumatoid arthritis: relationship between insulin resistance and disease activity. J Rheumatol 35(2):355\u2013357","journal-title":"J Rheumatol"},{"issue":"4","key":"5379_CR361","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1179\/acb.2007.035","volume":"62","author":"FM Oguz","year":"2007","unstructured":"Oguz FM, Oguz A, Uzunlulu M (2007) The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. Acta Clin Belg 62(4):218\u2013222. https:\/\/doi.org\/10.1179\/acb.2007.035","journal-title":"Acta Clin Belg"},{"issue":"1","key":"5379_CR362","first-page":"83","volume":"24","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J (2006) Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24(1):83\u201386","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"5379_CR363","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.2337\/dc19-0908","volume":"42","author":"B Trinh","year":"2019","unstructured":"Trinh B, Donath MY, L\u00e4ubli H (2019) Successful treatment of immune checkpoint inhibitor-induced diabetes with Infliximab. Diabetes Care 42(9):e153\u2013e154. https:\/\/doi.org\/10.2337\/dc19-0908","journal-title":"Diabetes Care"},{"issue":"4","key":"5379_CR364","doi-asserted-by":"publisher","first-page":"995","DOI":"10.22092\/ari.2021.355849.1728","volume":"76","author":"AS Netrebenko","year":"2021","unstructured":"Netrebenko AS, Gureev VV, Pokrovskii MV, Gureeva AV, Tsuverkalova YM, Rozhkov IS (2021) Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rats. Arch Razi Inst 76(4):995\u20131004. https:\/\/doi.org\/10.22092\/ari.2021.355849.1728","journal-title":"Arch Razi Inst"},{"issue":"4","key":"5379_CR365","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00296-014-3146-4","volume":"35","author":"HW Kim","year":"2015","unstructured":"Kim HW, Lee CK, Cha HS, Choe JY, Park EJ, Kim J (2015) Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. Rheumatol Int 35(4):727\u2013734. https:\/\/doi.org\/10.1007\/s00296-014-3146-4","journal-title":"Rheumatol Int"},{"key":"5379_CR366","doi-asserted-by":"publisher","first-page":"114426","DOI":"10.1016\/j.bcp.2021.114426","volume":"185","author":"NN Younis","year":"2021","unstructured":"Younis NN, Mohamed HE, Shaheen MA, Abdelghafour AM, Hammad SK (2021) Inactivation of Wnt\/\u03b2-catenin\/renin angiotensin axis by tumor necrosis factor-alpha inhibitor, infliximab, ameliorates CKD induced in rats. Biochem Pharmacol 185:114426. https:\/\/doi.org\/10.1016\/j.bcp.2021.114426","journal-title":"Biochem Pharmacol"},{"issue":"25","key":"5379_CR367","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Anti-TNF Therapy Against Congestive Heart Failure Investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107(25):3133\u20133140. https:\/\/doi.org\/10.1161\/01.CIR.0000077913.60364.D2","journal-title":"Circulation"},{"issue":"9","key":"5379_CR368","doi-asserted-by":"publisher","first-page":"e032172","DOI":"10.1161\/JAHA.123.032172","volume":"13","author":"C Livia","year":"2024","unstructured":"Livia C, Inglis S, Crespo-Diaz R, Rizzo S, Mahlberg R, Bagwell M, Hillestad M, Yamada S, Meenakshi Siddharthan DV, Singh RD, Li X, Arrell DK, Stalboerger P, Witt T, El Sabbagh A, Rihal M, Rihal C, Terzic A, Bartunek J, Behfar A (2024) infliximab limits injury in myocardial infarction. J Am Heart Assoc 13(9):e032172. https:\/\/doi.org\/10.1161\/JAHA.123.032172","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"5379_CR369","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-a","volume":"73","author":"DW Banner","year":"1993","unstructured":"Banner DW, D\u2019Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73(3):431\u2013445. https:\/\/doi.org\/10.1016\/0092-8674(93)90132-a","journal-title":"Cell"},{"issue":"7","key":"5379_CR370","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2337\/dc09-0054","volume":"32","author":"L Mastrandrea","year":"2009","unstructured":"Mastrandrea L, Yu J, Behrens T, Buchlis J, Albini C, Fourtner S, Quattrin T (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32(7):1244\u20131249. https:\/\/doi.org\/10.2337\/dc09-0054","journal-title":"Diabetes Care"},{"issue":"39","key":"5379_CR371","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1824-7288-39-64","volume":"14","author":"AN Olivieri","year":"2013","unstructured":"Olivieri AN, Iafusco D, Mellos A, Zanfardino A, Mauro A, Granato C, Gicchino MF, Prisco F, Perrone L (2013) Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto\u2019s thyroiditis successfully treated with etanercept. Ital J Pediatr 14(39):64. https:\/\/doi.org\/10.1186\/1824-7288-39-64","journal-title":"Ital J Pediatr"},{"issue":"11","key":"5379_CR372","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-014-0137-z","volume":"20","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Zhang Q, Ye EA, Steinle JJ (2014) Etanercept restores normal insulin signal transduction in \u03b22-adrenergic receptor knockout mice. J Neuroinflammation 20(11):137. https:\/\/doi.org\/10.1186\/s12974-014-0137-z","journal-title":"J Neuroinflammation"},{"issue":"5","key":"5379_CR373","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/ndt\/gfac290","volume":"38","author":"MM Abdelmageed","year":"2023","unstructured":"Abdelmageed MM, Kefaloyianni E, Arthanarisami A, Komaru Y, Atkinson JJ, Herrlich A (2023) TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment. Nephrol Dial Transplant 38(5):1139\u20131150. https:\/\/doi.org\/10.1093\/ndt\/gfac290","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"5379_CR374","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3899\/jrheum.161418","volume":"44","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga M, Kneepkens EL, van Dongen C, Nurmohamed MT (2017) The effects of 5-year Etanercept therapy on cardiovascular risk factors in patients with Psoriatic Arthritis. J Rheumatol 44(9):1362\u20131368. https:\/\/doi.org\/10.3899\/jrheum.161418","journal-title":"J Rheumatol"},{"issue":"11","key":"5379_CR375","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/annrheumdis-2020-217653","volume":"79","author":"S Plein","year":"2020","unstructured":"Plein S, Erhayiem B, Fent G, Horton S, Dumitru RB, Andrews J, Greenwood JP, Emery P, Hensor EM, Baxter P, Pavitt S, Buch MH (2020) Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-na\u00efve, early rheumatoid arthritis. Ann Rheum Dis 79(11):1414\u20131422. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217653","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"5379_CR376","doi-asserted-by":"publisher","first-page":"ii70","DOI":"10.1136\/ard.61.suppl_2.ii70","volume":"61","author":"R Rau","year":"2002","unstructured":"Rau R (2002) Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 61(Suppl 2):ii70\u2013ii73. https:\/\/doi.org\/10.1136\/ard.61.suppl_2.ii70","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5379_CR377","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/EJE-06-0693","volume":"156","author":"IC van Eijk","year":"2007","unstructured":"van Eijk IC, Peters MJ, Nurmohamed MT, van Deutekom AW, Dijkmans BA, Simsek S (2007) Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis. Eur J Endocrinol 156(3):291\u2013293. https:\/\/doi.org\/10.1530\/EJE-06-0693","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"5379_CR378","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21315\/mjms2018.25.4.5","volume":"25","author":"HA Shuwa","year":"2018","unstructured":"Shuwa HA, Dallatu MK, Yeldu MH, Ahmed HM, Nasir IA (2018) Effects of Adalimumab, an anti-tumour necrosis factor-alpha (TNF-\u03b1) antibody, on obese diabetic rats. Malays J Med Sci 25(4):51\u201362. https:\/\/doi.org\/10.21315\/mjms2018.25.4.5","journal-title":"Malays J Med Sci"},{"issue":"12","key":"5379_CR379","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.18502\/ijph.v50i12.7936","volume":"50","author":"Z Ding","year":"2021","unstructured":"Ding Z, Jiang H, Fan Y, Sun G (2021) Protective effect of Adalimumab on diabetic nephropathy by regulating TNF-\u03b1 signal pathway. Iran J Public Health 50(12):2536\u20132545. https:\/\/doi.org\/10.18502\/ijph.v50i12.7936","journal-title":"Iran J Public Health"},{"issue":"39","key":"5379_CR380","doi-asserted-by":"publisher","first-page":"e394624","DOI":"10.1590\/acb394624","volume":"2","author":"N\u00d6 Eliyatk\u0131n","year":"2024","unstructured":"Eliyatk\u0131n N\u00d6, \u0130\u015flek A, Durmaz S, Ayy\u0131ld\u0131z F, Rahman \u00d6 (2024) Can adalimumab prevent from acute effects of lipopolysaccharide induced renal injury in rats? Acta Cir Bras 2(39):e394624. https:\/\/doi.org\/10.1590\/acb394624","journal-title":"Acta Cir Bras"},{"issue":"6","key":"5379_CR381","doi-asserted-by":"publisher","first-page":"e15986","DOI":"10.7759\/cureus.15986","volume":"13","author":"R Plant","year":"2021","unstructured":"Plant R, Rafi Ahmed A, Mchale T, Giblin L (2021) A case of Adalimumab-Induced Granulomatous interstitial nephritis. Cureus 13(6):e15986. https:\/\/doi.org\/10.7759\/cureus.15986","journal-title":"Cureus"},{"issue":"3","key":"5379_CR382","doi-asserted-by":"publisher","first-page":"e226442","DOI":"10.1136\/bcr-2018-226442","volume":"12","author":"AK Bhagat Singh","year":"2019","unstructured":"Bhagat Singh AK, Jeyaruban AS, Wilson GJ, Ranganathan D (2019) Adalimumab-induced IgA nephropathy. BMJ Case Rep 12(3):e226442. https:\/\/doi.org\/10.1136\/bcr-2018-226442","journal-title":"BMJ Case Rep"},{"issue":"4","key":"5379_CR383","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/1346-8138.13661","volume":"44","author":"S Gkalpakiotis","year":"2017","unstructured":"Gkalpakiotis S, Arenbergerova M, Gkalpakioti P, Potockova J, Arenberger P, Kraml P (2017) Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: results of a pilot study. J Dermatol 44(4):363\u2013369. https:\/\/doi.org\/10.1111\/1346-8138.13661","journal-title":"J Dermatol"},{"issue":"1","key":"5379_CR384","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/03009740802363768","volume":"38","author":"PI Sidiropoulos","year":"2009","unstructured":"Sidiropoulos PI, Siakka P, Pagonidis K, Raptopoulou A, Kritikos H, Tsetis D, Boumpas DT (2009) Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients. Scand J Rheumatol 38(1):6\u201310. https:\/\/doi.org\/10.1080\/03009740802363768","journal-title":"Scand J Rheumatol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05379-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05379-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05379-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:12:26Z","timestamp":1762506746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05379-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":384,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5379"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05379-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This manuscript does not involve experiments on humans or animals, and therefore does not require ethical approval or participant consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and approved the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}